dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Rotterdam Convention

Sotsiaalministeerium · 26. veebruar 2019
Viit
1.4-2/601-1
Registreeritud
26. veebruar 2019
Dokumendi liik
Sissetulev kiri
Adressaat
Secretariat of the Basel, Rotterdam and Stockholm conventions
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2019
Vastutaja
Liis Kaar (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Rahvatervise osakond)
Lahendamise tähtaeg
29. märts 2019

Failid

  • 📎CRC14_Cover letter_PFOA_February 2019.pdf166 KB
  • 📎Draft DGD PFOA_February 2019.pdf917 KB
  • 📎E-kiri.pdf76 KB
  • 📎Working paper on preparing DGDs for chemicals.pdf728 KB

Sisu (failidest)

Excerpt from the Handbook of the Chemical Review Committee Working paper on preparing internal proposals and decision guidance documents for banned or severely restricted chemicals Introduction This document provides guidance to intersessional drafting groups of the Chemical Review Committee (CRC) in the preparation of decision guidance documents for banned or severely restricted chemicals. It is designed to clarify the purpose of each section of the decision guidance document and to characterize the information to be included. The working paper, originally developed by the interim CRC, was adopted at the first session of the CRC. Subsequent sessions of the CRC have reviewed and amended this working paper based on the experience gained in drafting decision guidance documents. This most recent version was adopted by the third session of the CRC with the understanding that it would continue to evolve in the light of future experience. Purpose This working paper is to serve as guidance to drafting groups established by the Chemical Review Committee for the preparation of decision guidance documents for banned or severely restricted chemicals in accordance with Article 5 of the Rotterdam Convention. This working paper is intended: (a) To clarify the purpose of each section of the decision guidance document; (b) To characterize the information to be included; (c) To define acceptable sources of information for each section. This working paper is expected to evolve as further experience is gained in the preparation of decision guidance documents. It is to be used by drafting groups preparing decision guidance documents for both pesticides and industrial chemicals. In this version of the working paper those sections which are potentially different for industrial chemicals and pesticides have been highlighted. If required, future versions of the working paper may be split into two separate working documents, one for pesticides and one for industrial chemicals. A separate working paper has been developed for the preparation of decision guidance documents for severely hazardous pesticide formulations in accordance with Article 6 of the Rotterdam Convention. In order to further facilitate the work of the drafting groups an electronic template of a draft decision guidance document has been prepared as a companion document to this working paper. General guidance In preparing each decision guidance document a standard cover/title page will be added as will a version of the standard introductory text developed at the fourth session of the interim Chemical Review Committee. This text provides a brief summary of the process through which the individual decision guidance document was developed and includes three separate sections an introduction, purpose and disclaimer. In cases where a decision guidance document includes more than one chemical (e.g. asbestos), a table of contents will facilitate the use of the document. Similarly the insertion of footers identifying the chemical should be included on each page. A standard list of “core” abbreviations has been prepared based on experience in drafting decision guidance documents to date. It is intended that this core list should serve as the basis for decision guidance documents for both industrial chemicals and pesticides and that it should be augmented by abbreviations used in the individual decision guidance documents relevant to the chemical(s) in question. This core list of abbreviations is appended to this working paper (appendix 1). As a general rule it is preferable that acronyms used only once in the text be spelled out rather than included in the list of abbreviations. In preparing a decision guidance document, it may be that not all sections are relevant to the chemical under consideration. It is preferable, in this case, to include a phrase along the lines of ‘not applicable’, rather than deleting the section or leaving it blank. This clearly indicates that the drafting group had considered that section. 1. Identification and uses Purpose: To provide an unequivocal identification of the chemical subject to the PIC procedure and its use as either a pesticide or an industrial chemical, or both. (a) This basic information should be obtainable from the submitted notifications and the supporting material available to the Committee prior to its decision to develop a decision guidance document. (b) CAS numbers for all forms of the chemical covered in the relevant notifications of final regulatory action should be included here. The scope of the chemical identified in this section (chemical description and associated CAS numbers) must be consistent with the recommendation by the Chemical Review Committee (CRC) for inclusion of the chemical in Annex III of the Convention. Should additional CAS numbers be found during the development of the decision guidance document, they should be brought to the attention of the CRC. If they do not broaden the scope of the original notification, they could be included here. (c) Chemical structural formula should be included if practicable. Structural formula may be found in standard references documents on pesticides e.g. The Pesticide Manual. Notes: Updated or additional information on trade names, formulation types and basic manufacturers for products moving in international trade may be identified through the responses to the call for information on on-going manufacture, use and trade of the chemical. The list of trade names, formulation types and manufacturers should, where possible, distinguish old products from those that are known to be moving in international trade. It is clear that a list of both manufacturers and trade names will be constantly changing, for this reason a generic disclaimer along the following lines should be considered: (a) Under trade names: (b) This is an indicative list of trade names. It is not intended to be exhaustive. (c) Under basic manufacturers: This is an indicative list of current and former manufacturers of XXX. It is not intended to be exhaustive. In accordance with article 7, when a chemical may be used as both a pesticide and an industrial chemical (a dual-use chemical), the decision guidance document should provide information on uses in both categories. A statement on “reported use in X category” or “no reported uses in X category” should be given (where X is either an industrial chemical for a pesticide decision guidance document or a pesticide for an industrial chemical). 2. Reasons for inclusion in the PIC procedure Purpose: To provide a generic statement that clearly identifies the use category (pesticide or industrial chemical) and whether the chemical is subject to a ban or severe restriction in the notifying countries. (a) References to any previous listing(s) under the PIC procedure should also be included, where relevant. (b) For dual-use chemicals, it will also be important to note when the PIC obligations do not apply to the use category that was not regulated. Example: [Chemical X] is included in the PIC procedure as a pesticide. It is has been listed on the basis of the final regulatory actions to severely restrict its use, notified by [Country 1], and to ban its use, notified by [Country 2]. No final regulatory actions relating to industrial chemical uses have been notified. List notifying countries alphabetically. 2.1. Final regulatory action Purpose: To provide a brief statement/summary of the final regulatory action(s) as reported by the notifying countries and the reasons for the actions taken (e.g., occupational health concerns, environmental concerns). (a) The text should reflect the reasoning used by the regulatory authority to underpin the national regulatory action(s) – for example, as presented in national law, regulation, gazette, legal journal, code. (b) Specific reference to the relevant directive or regulation for the reported regulatory action(s) should be included in annex 2. (c) The reason(s) stated should set the stage for the subsequent description of the underlying risk evaluation. National authorities should ensure that any technical legal references, if they are used, are accurate. 2.2. Risk evaluation Purpose: To provide a brief summary (no more than 1-2 pages) highlighting the key reported finding(s) of the national risk evaluation(s) that led to the regulatory action(s). (a) The text should reflect the reason(s) identified in the final regulatory action(s) by the notifying countries and include information on the uses that were permitted prior to the regulatory action. (b) In the interests of brevity, the text may include references to Convention Annexes I and II for additional details. Note: Depending on the chemical and the finding(s) of the national risk evaluations, this section may provide information on an individual country basis, or, where there are multiple country notifications based on common human health or environmental concerns, the information may be summarized and combined. It would also be useful to highlight the differences in regulatory actions, if they are not already obvious. 3. Protective measures that have been applied concerning the chemical Purpose: To highlight measures taken to reduce exposure, in the first instance through regulatory controls or measures and secondly through other measures (administrative, non-legal/voluntary codes of practice, field practice, etc.) recalling that: (a) A ban in the regulated category of use eliminates all exposure (occupational or environmental); and (b) A severe restriction in the regulated category of use allows continued use in a manner that reduces risk to an “acceptable” level. 3.1. Regulatory measures to reduce exposure Purpose: To provide information on the regulatory measures taken to ban or severely restrict the chemical and associated products. (a) for bans, the risk has been eliminated and therefore a simple explanation of the risk management strategy to deal with existing stocks may be enough; and (b) for severe restrictions, briefly describe the regulatory measures taken/set in place to reduce the risk to acceptable levels - e.g. by restricting access to trained/certified applicators or requiring purchasers to be licensed. 3.2. Other measures to reduce exposure This section is primarily intended for additional information from the notifying country(ies) on chemicals that have been severely restricted e.g. chemicals where for which virtually all use has been prohibited. For most banned chemicals this section would not be completed. The exception is where there was relevant chemical specific information from either the notifying country or international sources on possible risk mitigation measures. Purpose: To provide information about non-regulatory measures (including technical and field-level arrangements) for severely restricted chemicals taken/set in place to reduce exposure and ensure that risk remains at an acceptable level for the uses that are permitted to continue. Information could include, for example changing the type of formulation or application equipment used, specifying the personal protective equipment or clothing required. Where available, information from the notifying country or international sources of information on chemical specific risk mitigation measures may also be referenced. Examples may include publications from the International Labour Organisation or International Standards Organisation. It is not intended that generic information on handling hazardous chemicals would be included in this section. Note: In order to maintain the timeliness and accuracy of this information, it is preferable to include references to additional sources of information (electronic links, etc) for a specific chemical on the Rotterdam Convention website. New sources of such information could also be included in a series of up-dates that could be distributed to designated national authorities along with the PIC circular. 3.3. Alternatives Purpose: To provide countries with brief information about alternatives that have been identified by the notifying country or countries and others where available. It is not be feasible for the decision guidance document to contain a comprehensive list of specific pest crop complexes and recommended pesticides or non-chemical alternatives, particularly for pesticides that have a broad spectrum of activity. As the available alternatives are constantly evolving, identifying sources of information is likely to be more useful and more reliable than a list of specific recommendations. (a) Notifying countries may provide information about chemical and non-chemical alternatives that are being used within their jurisdictions. Detailed information can be included in annex 2. (b) Information from sources other than the notifying country might be referenced here with details on where the information might be found provided to DNAs through the PIC Circular and the Rotterdam Convention website (see following note). Note: While recognizing that a range of chemical and non-chemical alternatives may be available, this section should include a generic statement on the need for caution in considering them or using them and should remind parties of the need to ensure that they are appropriate to national circumstances. In order to maintain the timeliness and accuracy of this information, it is preferable to include references to additional sources of information (electronic links, etc.) for a specific chemical on the Rotterdam Convention website. Such new sources of such information could be included in a series of up-dates that could be distributed to designated national authorities along with the PIC circular and also used in workshops. The following is an example of standard text for this section related to pesticides. There are a number of alternative methods involving chemical and non-chemical strategies, including alternative technologies available, depending on the individual crop-pest complex under consideration. Countries should consider promoting, as appropriate, integrated pest management (IPM) and organic strategies as a means of reducing or eliminating the use of hazardous pesticides. Advice may be available through National IPM focal points, the FAO, IFOAM (International Federation of Organic Movements) and agricultural research or development agencies. Where it has been made available by governments, additional information on alternatives to XXXX may be found on the Rotterdam Convention website www.pic.int. It is essential that before a country considers substituting alternatives, it ensure that the use is relevant to its national needs and the anticipated local conditions of use. The hazards of the substitute materials and the controls needed for safe use should also be evaluated. For industrial chemicals, the final paragraph above should be used, to indicate the need to consider the hazards associated with possible alternatives. National alternatives should be included, and if international organisations have discussed alternatives in reviews etc. this information could also be included. 3.4. Social and economic effects This section would only be completed where Notifying Countries have undertaken specific studies of the social and economic effects related to their final regulatory action(s) and wish to report on their findings. Note: Most countries do not undertake rigorous social and economic studies that are relevant beyond their own jurisdictions, but they may provide information on alternatives when a country took an action to restrict a chemical. This information is optional. When reported, there will need to be a caveat that countries consider the results of this information in the context of their own national conditions. 4. Hazards and risks to human health and/or the environment 4.1 Hazard Classification Purpose: To provide a brief summary of internationally recognized classifications applied to the chemical(s) for which the decision guidance document has been prepared. (a) This section should focus on internationally recognized standards such as IARC, WHO/IPCS classification systems. (i) The standard reference for LD50 values is the most recent edition of the WHO/IPCS publication, recommended classification of pesticides by hazard and guidelines to classification. The WHO classification schemes for pesticides as well as its formulations are based on oral or dermal toxicity. According to the WHO guideline, the route which indicate greater hazard would be chosen for its classification. (ii) As far as possible, information on the WHO hazard classification of liquid and solid formulations should be included. (b) The US EPA and European Union classification systems have been included as they are widely used by many countries as a reference. (c) All references should include the date when they were established. Note: It is not intended that national standards be included here, notifying countries should include their national classification schemes in Annex 2. The following is an example of how this information might be presented: 4. Hazards and Risks to human health and the environment 4.1 Hazard Classification WHO / IPCS Technical product Insert classification e.g. Class Ia (extremely hazardous) Classification based on oral or dermal toxicity in rats a.i.: LD50: (WHO reference) Formulations a.i. (%) Hazard class Liquid Solid IARC Group 3: the agent is not classified as to its carcinogenicity to humans. (IARC reference) European Classification of the active substance is (Commission Directive reference): Union T (toxic) Xi (Irritant) N (dangerous for the environment) R 24/25 (Toxic in contact with skin/ if swallowed) R 36 (Irritating to eyes) R 50/53 (Very toxic to aquatic organisms / may cause long-term adverse effects in the aquatic environment) US EPA Toxicity Class I (formulation) (EPA reference) 4.2. Exposure limits Purpose: To provide a brief summary of internationally recognized exposure limits as applied to the chemical(s) subject to the decision guidance document. (a) This section should focus on those exposure limits that are internationally recognized, e.g., Codex levels in food, WHO drinking water guidelines, etc. (b) All references should include the date when they were established and the date of any subsequent review by the FAO/WHO Joint Meeting on Pesticide Residues (JMPR), etc. (c) It is not intended to capture occupational exposure limits such as Threshold Limit Values (TLVs) for pesticides largely because of the widely differing ways in which they may be calculated Note: It is not intended that national standards be included here as their applicability to other countries is limited without a good understanding of how the limits were derived. Notifying countries could include them in Annex 2 if they feel it is appropriate and necessary. If no international exposure limits are available, the words ‘not applicable for this chemical’ could be inserted. 4.3 Packaging and labelling Purpose: To provide a quick reference to existing standards for packaging and labelling of the chemical. This section should focus on internationally recognized classifications established by the United Nations Committee of Experts on the Transport of Dangerous Goods, and on the Globally Harmonized System of Classification and Labelling of Chemicals (if used), the International Maritime Dangerous Goods Code, etc., along with relevant explanatory text if applicable (i.e. for specific requirements). Note: In the case of pesticides, this section should include a generic statement on the availability of further specific guidance on appropriate symbols and label statements for individual pesticides and formulations in the FAO Guidelines on Good Labelling Practice for Pesticides. 4.3 Packaging and labelling The United Nations Committee of Experts on the Transportation of Dangerous Goods classifies the chemical in: Hazard Class and Packing Group: International Maritime Dangerous Goods (IMDG) Code Transport Emergency Card 4.4. First aid Purpose: To provide a quick reference to internationally recognized information on the treatment of chemical poisoning (pesticides and industrial chemicals) available at the time of publication of the decision guidance document. (a) Reference should be generic and include the most recent WHO/IPCS recommendation. (b) It should note any aspects specific to the chemical cited in the decision guidance document. (c) A reference to the WHO website for other relevant information might also be included www.inchem.org Notes: For chemicals that are not acutely toxic, this section may not be relevant and could be completed with the statement “not applicable to this chemical”. Recognizing that a range of first-aid treatments may be available, this section should include a generic statement on the need for caution and should remind parties of the need to ensure that this information is in compliance with any national standards that may exist. 4.5. Waste management Purpose: To ensure that countries are aware of the need for appropriate management of wastes and to provide references to relevant guidance and other sources of information. (a) This section should include references to appropriate internationally recognized guidelines such as those developed by FAO for pesticides. (b) Particular attention should be drawn to the relevant terms of international agreements – the Basel Convention on the Control of Transboundary Movements of Hazardous Wastes and their Disposal. (c) Notifying countries may wish to note specific actions taken to avoid the creation of stockpiles, including arrangements to permit use of existing stocks during a phase-out period. Annex 1 Further information on the chemical Annex 1 contains information submitted by the notifying countries based on the national assessments which were used to support the reported final regulatory action. The results of international reviews such as those of WHO/IPCS/JMPR/IARC should also be included in this section where available and considered relevant. Subsequent evaluations or reviews of the chemical from Parties, other than those that submitted the notifications of final regulatory actions may be submitted to the secretariat for posting on the Rotterdam Convention website. Purpose: To provide an overall summary of information on the chemical for which the reported regulatory action(s) have been taken, including physico-chemical properties of the substance and/or product(s) and the results of toxicological and ecotoxicity studies. The decision guidance document is not intended to be a scientific treatise on a chemical. The emphasis should be on the concerns that formed the basis of the reported final regulatory action(s). For example, if the sole basis of the reported regulatory action(s) is unacceptable occupational exposure, this annex section should focus on human health effects rather than environmental aspects. The principal headings in this annex generally reflect those used by OECD countries and the European Union in their monographs. This approach will assist all countries, especially developing countries, which may have used an OECD/European Union monograph as the basis for the risk evaluation supporting their final regulatory action(s). The generic headings and general guidance on content should facilitate consistency in the format and content of decision guidance documents. (a) The introduction to the annex should describe its content. This should include reference to any relevant international reviews (e.g. those of OECD, IPCS/WHO or IARC) and how this information has been incorporated into the document. For example whether or not the results of an international assessment (toxicological or ecotoxicological) are substantively different from those of the notifying countries should be noted. In the case of mammalian toxicity a summary of the two evaluations highlighting the similarities or differences as appropriate may be included in section 2.2.7 of this annex (see below). (b) The level of detail within the subheadings may be adjusted to accommodate the information used to support the notified regulatory action and available to the drafting group. (See appendix 2 to the present note for a list of the headings and subheadings and an indication of the points that may be included under each.) (c) Specific sections on exposure/risk evaluation have been included for both human health and environmental fate and effects. These sections should include specific information from notifying countries on the basis for their final regulatory action. General comments Tabular summaries of information should be used wherever possible; this should not, however, be at the expense of a clearly stated analysis that explains how the data were used in the risk evaluation that formed the basis for the reported regulatory action. The level of detail will be a function of the information that is available and will need to be determined on a case-by-case basis. As a guiding principle, however, the focus should be on those end points that were the basis for the risk evaluation underlying the notified final regulatory action. For example, in those instances where a chemical was found to be a reproductive toxin and this was the basis for the regulatory action, greater detail would be expected on the supporting studies e.g. NOEL/NOAEL/LOEL, than on end points for which the results may have been negative (i.e., simply stating “was not carcinogenic”). In the case of universally recognized regulatory guidelines or limits such as the acceptable daily intake (ADI) or acute reference dose (ARfD), details on the supporting studies on which they are based should be included. LD50 and LC50 data can vary widely for a chemical. In order to avoid apparent discrepancies in the information reported, it may be better to report a range of values wherever possible, particularly where the results from more than one source are combined. In reporting toxicity data reference should be made to the duration of exposure for all studies reported, including acute toxicity studies, where it is available or known. In some cases, the notifying parties may reach different conclusions on individual end points related to human health or the environment. Furthermore, the situation may arise where there has been an evaluation of the chemical at the international level e.g. by the OECD, WHO/IPCS or IARC that has reached conclusions that differ from those of the findings of the notifying parties. In such cases the following approaches should be considered: (a) It is intended that these differences be clearly indicated in the decision guidance document, where they concern “pivotal end points” within the risk evaluation, that is those end points upon which the final regulatory action was based. (b) Where there are differences in interpretation of data concerning specific end points, but the differences do not affect the outcome of the final regulatory action or the conclusions of the international review, the degree to which these details will be reflected in the decision guidance document will need to be considered on a case-by-case basis. (c) Section 2.2.7 Summary of mammalian toxicity and overall evaluation – this section provides an opportunity to summarize the conclusions of the toxicological evaluations from the notifying countries as well as any relevant international reviews e.g. WHO/IPCS/IARC. Where information from an international evaluation such as an IPCS Environmental Health Criteria document is included, the reference in the text should be to this document, rather than to the individual papers quoted therein. Where information from the risk evaluations by the notifying Parties is included, it is sufficient if this source is indicated, rather than the specific studies or reviews referred to. Specific comments - details of proposed subheading may be found in appendix 2 1. Physico-chemical properties This section characterizes the chemical, based on national evaluations and recognized information sources e.g. Pesticides Manual, A World Compendium (Crop Protection Publications - ISBN 0 948404 79 5) 2. Toxicological properties 2.1. General information This section should provide brief information on the mode of action, symptoms of poisonings and on absorption, distribution, excretion and metabolism in mammals. It can be retrieved from the notifications as well as from internationally recognized sources such as the Pesticide Manual or WHO/IPCS/JMPR/IARC evaluations. 2.2 Toxicity studies This section lays out the toxicological profile of the chemical as assessed by the notifying countries at the time of their final regulatory actions(s). It should also include a comparative summary of any IPCS/WHO international evaluations, such as those of WHO/IPCS/JMPR, where they are available and considered relevant. This summary should be included in section 2.2.7 Summary of mammalian toxicity and overall evaluation. (a) In the interests of brevity, where multiple studies for the same end point exist, the drafting group should report in a summary form, rather than report on each individual study. The level of detail will need to be considered on a case-by-case basis. It is generally accepted that where a review document has been used as the source of the information, the review document is cited rather than the individual studies. (b) Under the heading Summary of mammalian toxicity and overall evaluation (section 2.2.7), the drafting group should provide a concise summary of key end points, in order to facilitate comparisons among different evaluations and to improve understanding of those end points considered in the human exposure/risk evaluation section (see the preceding section on General comments). 3. Human exposure/risk evaluation This section highlights in greater detail those human exposure and risk factors that led to the regulatory control action(s), focusing on the major exposure routes (i.e. food, air, water and occupation). (a) Information concerning epidemiological studies or poisoning incidents that were considered by the notifying country in taking the reported regulatory action could be inserted under the subheading Medical data (section 3.5). Note: Where the reported regulatory actions are based on environmental effects, it is anticipated that this section of the decision guidance document would be minimal. 4. Environmental fate and effects This section provides information on the environmental fate characteristics (Fate, section 4.1) of the chemical and the results of ecotoxicity studies (Effects on non-target organisms, section 4.2). Note: Specific subheadings for the parameters of persistence and bio-concentration have been included to facilitate the identification of chemicals with the characteristics of persistent organic pollutants (POPs). 5. Environmental exposure/risk evaluation This section highlights in greater detail those environmental fate factors that led to the regulatory control action(s) and should include a summary of the overall risk evaluation. Note: Where the reported regulatory actions are based on human health concerns (e.g., risks to workers), it is anticipated that this section of the decision guidance document would be minimal. Annex 2. Details on final regulatory actions reported Annex 2 reports expand upon the information presented regarding the final regulatory action(s) of each notifying country. This annex should reflect the information provided in the notification of regulatory action form and presented to the Chemical Review Committee for review. The annex represents an opportunity for notifying countries to provide increased detail on aspects of the regulatory decision that they may wish to include. Annex 3. Addresses of designated national authorities This annex should provide detailed information on how to contact the designated national authorities of the notifying countries, including the name of a contact person; mailing address; telephone, fax and telex numbers; and email address. Annex 4. References This annex includes a list of the sources of information cited in the decision guidance document. Where information from a review document has been used, the reference should be to the review document, rather than to the individual papers within the review. Original papers should only be cited where they have been considered individually, rather than as a component of the review. List References under headings as appropriate. The following is an example for a reference list: Regulatory actions Decision by the Norwegian Agricultural Inspection Service (NAIS) 22.10.2002 (200200430 IP/hmo). Supporting documentation provided by Country X Environmental Health Criteria No. 165: Inorganic Lead. IPCS/WHO 1995 (an example of a review document) Supporting documentation provided by Country Y Sebastien P, Begin R, & Masse S (1990) Mass number and size of lung fibres in the pathogenesis of asbestosis in sheep. Int J Exp Pathol, 71: 1-10. (individual paper cited if the original paper was used in the preparation of the DGD) Others WHO (2003): Health Risk of Persistent Organic Pollutants from Long-Range Transboundary Air Pollution. Relevant guidelines and reference documents FAO/WHO Food Standards (2010). CODEX Alimentarius. FAO (2006) Framework of FAO Guidelines on Pesticide Management in support of the Code of Conduct. http://www.fao.org/ag/AGP/AGPP/Pesticid/Code/Guidelines/Framework.htm Appendix I: Standard Core Set of Abbreviations1 STANDARD CORE SET OF ABBREVIATIONS < less than < less than or equal to > greater than > greater than or equal to µg microgram m micrometre ARfD acute reference dose a.i. active ingredient ADI acceptable daily intake AOEL acceptable operator exposure level b.p. boiling point bw body weight o C degree Celsius (centigrade) CAS Chemical Abstracts Service cc cubic centimetre cm centimetre DNA deoxyribonucleic acid DT50 dissipation time 50% EC European Community EC50 median effective concentration ED50 median effective dose EEC European Economic Community EHC Environmental Health Criteria EU European Union FAO Food and Agriculture Organization of the United Nations g gram h hour ha hectare i.m. intramuscular i.p. intraperitoneal IARC International Agency for Research on Cancer IC50 median inhibitory concentration ILO International Labour Organisation IPCS International Programme on Chemical Safety IPM Integrated Pest Management IUPAC International Union of Pure and Applied Chemistry 1 This core list should serve as the basis for DGDs for industrial chemicals, pesticides and severely hazardous pesticide formulations. It should be augmented by abbreviations used in the individual DGDs relevant to the chemical(s) in question. Definitions and spelling should, as far as practicable, follow the IUPAC glossary of terms in toxicology and the IUPAC glossary of terms relating to pesticides in their current editions. As a general rule it is preferable that acronyms used only once in the text be spelled out rather than included in the list of abbreviations. STANDARD CORE SET OF ABBREVIATIONS JMPR Joint FAO/WHO Meeting on Pesticide Residues (Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and a WHO Expert Group on Pesticide Residues) k kilo- (x 1000) kg kilogram Koc soil organic partition coefficient Kow octanol–water partition coefficient kPa kilopascal L litre LC50 median lethal concentration LD50 median lethal dose LOAEL lowest-observed-adverse-effect level LOEL lowest-observed-effect level m metre m.p. melting point mg milligram ml millilitre mPa millipascal MRL maximum residue limit MTD maximum tolerated dose ng nanogram NOAEC no-observed-adverse-effect concentration NOAEL no-observed-adverse-effect level NOEC no-observed-effect concentration NOEL no-observed-effect level OECD Organisation for Economic Co-operation and Development PEC predicted environmental concentration Pow octanol-water partition coefficient, also referred to as Kow PPE personal protective equipment ppm parts per million (used only with reference to the concentration of a pesticide in an experimental diet. In all other contexts the terms mg/kg or mg/L are used). RfD reference dose (for chronic oral exposure; comparable to ADI) SMR standard(ized) mortality ratio STEL short-term exposure limit TER toxicity exposure ratio TLV threshold limit value TWA time-weighted average UNEP United Nations Environment Programme USEPA United States Environmental Protection Agency UV ultraviolet VOC volatile organic compound w/w weight for weight WHO World Health Organization wt weight Appendix 2: Headings for Annex I and a list of information points that could be included under each 1. Physico-chemical properties 2. Toxicological properties 2.1. General 2.1.1. Mode of action 2.1.2. Symptoms of poisoning 2.1.3. Absorption, distribution, excretion and metabolism in mammals  Rate and extent of absorption  Distribution  Potential for accumulation  Rate and extent of excretion  Metabolism in animals  Toxicologically significant compounds (animals, plants and environment) 2.2. Toxicology studies 2.2.1. Acute toxicity  Rat LD50 oral  Rat LD50 dermal  Rat LC50 inhalation  Skin irritation  Eye irritation  Skin sensitization (test method used and result) 2.2.2. Short term toxicity  Target/critical effect  Oral  Dermal  Inhalation 2.2.3. Genotoxicity (including mutagenicity) 2.2.4. Long term toxicity and carcinogenicity  Target/critical effect  Relevant NOAEL/NOEL  Carcinogenicity 2.2.5. Effects on reproduction  Reproduction target/critical effect  Lowest relevant reproductive NOAEL/NOEL  Developmental target/critical effect  Lowest relevant developmental NOAEL / NOEL 2.2.6. Neurotoxicity/delayed neurotoxicity  Acute neurotoxicity  Subchronic neurotoxicity  Special studies (where available)could include human immunotoxicity studies 2.2.7. Summary of mammalian toxicity and overall evaluation  include summary of key findings of relevant international reviews e.g. WHO/IPCS/IARC evaluations 3. Human exposure/risk evaluation 3.1. Food 3.2. Air 3.3. Water 3.4. Occupational 3.5. Medical data contributing to regulatory decision – could include:  Report on medical surveillance on manufacturing plant personnel  Report on clinical cases and poisoning incidents  Observations on exposure of the general population and epidemiological studies 4. Environmental fate and effects 4.1. Fate 4.1.1. Soil  Field dissipation  Aerobic and anaerobic degradation  Rate of degradation  Adsorption/desorption  Mobility 4.1.2. Water  Route and rate of degradation 4.1.3. Air  Fate and behaviour 4.1.4. Bioconcentration and bioaccumulation 4.1.5. Persistence 4.2. Effects on non-target organisms 4.2.1. Terrestrial vertebrates  Acute/chronic toxicity mammals  Acute/chronic toxicity birds  Dietary toxicity birds  Reproductive toxicity birds  Other 4.2.2. Aquatic species  Fish  Invertebrates  Algal species  Aquatic plants  Other 4.2.3. Honey bees and other arthropods 4.2.4. Earthworms 4.2.5. Soil microorganisms 4.2.6. Terrestrial plants 5. Environmental exposure/risk evaluation Specific reference as appropriate to the following 5.1. Terrestrial vertebrates  Mammals/birds 5.2. Aquatic species  Fish/invertebrates/algal species/aquatic plants 5.3. Honey bees  Other arthropods 5.4. Earthworms 5.5. Soil microorganisms 5.6. Summary – overall risk evaluation. ROTTERDAM CONVENTION Secretariat of the Rotterdam Convention Secretariat of the Rotterdam Convention United Nations Environment Programme Food and Agriculture Organization of the United Nations Office Address: International Environment House 1 Viale delle Terme di Caracalla, 00153 Rome, Italy 11–13, chemin des Anémones, 1219 Châtelaine, Geneva, Switzerland Tel.: +39 06 5705 2061 ¦ Fax: +39 06 5705 3224 ¦ E-mail: [email protected] Postal Address: c/o Palais des Nations, 8-14, avenue de la Paix, 1211 Geneva 10, Switzerland Tel.: +41 (0) 22 917 8271 ¦ Fax: +41 (0) 22 917 8098 ¦ E-mail: [email protected] Date: 20 February 2019 Subject: Invitation to review and submit comments on the internal proposal of draft decision guidance document (DGD) for perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds Dear Sir, Dear Madam, The fourteenth meeting of the Chemical Review Committee of the Rotterdam Convention was held from 11 to 14 September 2018 in Rome. The report of the meeting (UNEP/FAO/RC/CRC.14/10) is available on the Convention’s website: http://www.pic.int/tabid/7391/Default.aspx. At the meeting, the Committee adopted decision CRC-14/5, on perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds, by which it adopted the rationale for the Committee’s conclusion that the notifications of final regulatory action submitted by Norway and Canada in respect of those chemicals in the industrial category met the criteria of Annex II to the Convention as set out in set out in the annex to that decision. By the same decision, the Committee recommended, in accordance with paragraph 6 of Article 5 of the Convention, that the Conference of the Parties list PFOA, its salts and PFOA-related compounds in Annex III to the Convention as industrial chemicals and decided, in accordance with paragraph 1 of Article 7 of the Convention, to prepare a draft decision guidance document for those chemicals. The Committee established an intersessional drafting group to prepare the draft decision guidance document on PFOA, its salts and PFOA-related compounds. Pursuant to the workplan adopted at the Committee’s fourteenth meeting (UNEP/FAO/RC/CRC.14/10, annex III), the intersessional drafting group has prepared an internal proposal of the draft decision guidance document on PFOA, its salts and PFOA-related compounds. All Parties and observers to the Rotterdam Convention are invited to review the attached internal proposal and to submit comments to the Committee no later than 29 March 2019. Submissions are most appreciated in electronic files by e-mail to: [email protected]. To: Rotterdam Convention official contact points, national focal points Cc: Representatives of permanent missions to the United Nations Office at Geneva Secretariat of the Rottei-dam Convention Page 12 For your information, the "working paper on preparing internal proposals and decision guidance documents for banned and severely restricted chemicals" is enclosed in this letter. If you have any questions regarding this invitation, please contact Ms. Kei Ohno Woodall, Secretariat of the Rotterdam Convention (Email: [email protected]; Tel.: +41 22 917 8201). Yours sincerely, Rolph Payet Executive Secretary Rotterdam Convention Operation of the prior informed consent procedure for banned or severely restricted chemicals Draft Decision Guidance Document Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds Secretariat of the Rotterdam Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade Introduction The objective of the Rotterdam Convention is to promote shared responsibility and cooperative efforts among Parties in the international trade of certain hazardous chemicals in order to protect human health and the environment from potential harm and to contribute to their environmentally sound use, by facilitating information exchange about their characteristics, by providing for a national decision-making process on their import and export and by disseminating these decisions to Parties. The Secretariat of the Convention is provided jointly by the United Nations Environment Programme (UNEP) and the Food and Agriculture Organization of the United Nations (FAO). Candidate chemicals1 for inclusion in the prior informed consent (PIC) procedure under the Rotterdam Convention include those that have been banned or severely restricted by national regulatory actions in two or more Parties 2 in two different regions. Inclusion of a chemical in the PIC procedure is based on regulatory actions taken by Parties that have addressed the risks associated with the chemical by banning or severely restricting it. Other ways might be available to control or reduce such risks. Inclusion does not, however, imply that all Parties to the Convention have banned or severely restricted the chemical. For each chemical included in Annex III of the Rotterdam Convention and subject to the PIC procedure, Parties are requested to make an informed decision whether they consent or not to the future import of the chemical. At its […] meeting, held in […] on […], the Conference of the Parties agreed to list perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds in Annex III of the Convention and adopted the decision-guidance document with the effect that these chemicals became subject to the PIC procedure. The present decision-guidance document was communicated to designated national authorities on […], in accordance with Articles 7 and 10 of the Rotterdam Convention. Purpose of the decision guidance document For each chemical included in Annex III of the Rotterdam Convention, a decision-guidance document has been approved by the Conference of the Parties. Decision-guidance documents are sent to all Parties with a request that they make a decision regarding future import of the chemical. Decision-guidance documents are prepared by the Chemical Review Committee. The Committee is a group of government-designated experts established in line with Article 18 of the Convention, which evaluates candidate chemicals for possible inclusion in Annex III of the Convention. Decision-guidance documents reflect the information provided by two or more Parties in support of their national regulatory actions to ban or severely restrict the chemical. They are not intended as the only source of information on a chemical nor are they updated or revised following their adoption by the Conference of the Parties. There may be additional Parties that have taken regulatory actions to ban or severely restrict the chemical and others that have not banned or severely restricted it. Risk evaluations or information on alternative risk mitigation measures submitted by such Parties may be found on the Rotterdam Convention website (www.pic.int). Under Article 14 of the Convention, Parties can exchange scientific, technical, economic and legal information concerning the chemicals under the scope of the Convention including toxicological, ecotoxicological and safety information. This information may be provided directly to other Parties or through the Secretariat. Information provided to the Secretariat will be posted on the Rotterdam Convention website. Information on the chemical may also be available from other sources. Disclaimer The use of trade names in the present document is primarily intended to facilitate the correct identification of the chemical. It is not intended to imply any approval or disapproval of any particular company. As it is not possible to include all trade names presently in use, only a number of commonly used and published trade names have been included in the document. While the information provided is believed to be accurate according to data available at the time of preparation of the present decision-guidance document, FAO and UNEP disclaim any responsibility for omissions or any consequences that may arise there from. Neither FAO nor UNEP shall be liable for any injury, loss, damage or prejudice of any kind that may be suffered as a result of importing or prohibiting the import of this chemical. 1 According to the Convention, the term “chemical” means a substance, whether by itself or in a mixture or preparation and whether manufactured or obtained from nature, but does not include any living organism. It consists of the following categories: pesticide (including severely hazardous pesticide formulations) and industrial. 2 According to the Convention, the term “Party” means a State or regional economic integration organization that has consented to be bound by the Convention and for which the Convention is in force. 2 The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of FAO or UNEP concerning the legal status of any country, territory, city or area or of its authorities or concerning the delimitation of its frontiers or boundaries. 3 STANDARD CORE SET OF ABBREVIATIONS < less than < less than or equal to > greater than > greater than or equal to µg Microgram m micrometre AFFF Aqueous Film Forming Foam BAF Bioaccumulation factor BCF Bioconcentration factor bw body weight BMDL Benchmark Dose lower confidence bound BMF Biomagnification factor BMR Benchmark Response o C degree Celsius (centigrade) CAS Chemical Abstracts Service cm centimetre DNA deoxyribose nucleic acid DT50 dissipation time 50% DfE Design for the Environment (US EPA program) dw dry weight EC European Community EC50 median effective concentration ECHA European Chemicals Agency EEC European Economic Community EPS Expanded polystyrene EU European Union FAO Food and Agriculture Organization of the United Nations g gram h hour IARC International Agency for Research on Cancer IPCS International Programme on Chemical Safety IUPAC International Union of Pure and Applied Chemistry k kilo- (x 1000) kg kilogram L litre LC50 median lethal concentration LD50 median lethal dose LOAEL lowest-observed-adverse-effect level lw liquid weight m metre mg milligram ml millilitre MAK maximum workplace concentration (Germany) MW Molecular Weight NES no effects at saturation 4 STANDARD CORE SET OF ABBREVIATIONS ng nanogram NOAEL no-observed-adverse-effect level NOEC no-observed-effect concentration NOHSC National Occupational Health and Safety Commission OECD Organisation for Economic Co-operation and Development PFAS Per- and Polyfluoroalkyl Substances PFCA Perfluoroalkyl carboxylic acids POPRC Persistent Organic Pollutants Review Committee of the Stockholm Convention PPE personal protective equipment ppm parts per million (used only with reference to the concentration of a pesticide in an experimental diet. In all other contexts the terms mg/kg or mg/L are used). PTFE polytetrafluoroethylene TH Thyroid hormone TMF Trophic magnification factor TSH Thyroid-stimulating hormone UNEP United Nations Environment Programme US EPA United States Environmental Protection Agency w/w weight for weight WHO World Health Organization wt weight wwt Wet weight 5 Decision guidance document for a banned or severely restricted chemical PERFLUOROOCTANOIC ACID (PFOA), ITS Published: SALTS AND PFOA-RELATED COMPOUNDS 1. Identification and uses (see Annex 1 for further details) Common name Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds Chemical name and PFOA and its salts and esters; other names or synonyms C8; perfluorooctanoate; pentadecafluoro octanoic acid; perfluoroheptanecarboxylic acid; perfluoro-n-octanoic acid; Fluorad FC-26; perfluorocaprylic acid; Perfluorooctanoic acid, which has the molecular formula C7F15CO2H, and its salts. Compounds that consist of a perfluorinated alkyl group that has the molecular formula CnF2n+1 in which n = 7 or 8 and that is directly bonded to any chemical moiety other than a fluorine, chlorine or bromine atom; Collectively referred to as PFOA. Octanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro- Molecular formula C8HF15O2 (PFOA) Chemical structure CAS-No.(s) The following PFOA and its related compounds CAS-numbers have been specified in the notifications from Canada and Norway: Free Acid (X = OM+; M = H) [CAS no. 335-67-1] Ammonium Salt (X = OM+; M = NH4) [CAS no. 3825-26-1] Sodium Salt (X = OM+; M = Na) [CAS no. 335-95-5] Potassium Salt (X = OM+; M = K) [CAS no. 2395-00-8] Silver Salt (X = OM+; M = Ag) [CAS no. 335-93-3] Acid Fluoride (X = F) [CAS no. 335-66-0] Methyl Ester (X = CH3) [CAS no. 376-27-2] Ethyl Ester (X = CH2-CH3) [CAS no. 3108-24-5] Harmonized System 29159070 Customs Code Other numbers INDEX no: 607-704-00-2 EC no: 206-397-9, EC no: 223-320-4 (ammonium salt); EC no: 206-404-5 (sodium salt) RTECS no: RH0781000 EINECS# 206-397-9 Category Industrial Regulated category Industrial chemical 6 Use(s) in regulated Canada: category Primarily used as water, oil and grease repellants; as surfactants; and as spreading and wetting agents. AFFFs may also contain APFO [PFOA ammonium salt] as a component or a contaminant. Norway: Used in several applications, i.e. coating agent for carpets, textiles, furniture, shoes, paper, food wraps, printing plates but also in paint, floor wax, glue and photographic film. Often PFOA is present in products as a chemical impurity or as trace amounts of remaining starting materials from the production of other perfluorinated compounds, e.g. side-chain fluorinated polymers. PFOA has been found in imported products like textiles treated with perfluorinated compounds in order to make them water and stain repellent. PFOA may also be found in food contact materials with non-stick properties. PFOA was previously often present in ski wax in small amounts as a chemical impurity of the perfluorinated constituents in the wax. Trade names Not available. Formulation types Not relevant. Uses in other Canada and Norway: categories There was historical use of PFOA as a formulant in some pesticides in Canada which has recently ceased. Currently, no reported use as a pesticide. Basic manufacturers 3M, USA (until 2002) Arkema, Asahi, BASF, Clariant, Daikin, 3M/Dyneon, DuPont and Solvay Solexis Source: USEPA, 2015 This is an indicative list of known current and former manufacturers. It is not intended to be exhaustive. 2. Reasons for inclusion in the PIC procedure Perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds (subsequently referred to as PFOA) are included in the PIC procedure in the industrial chemical category. PFOA is listed on the basis of final regulatory actions notified by Canada and Norway that severely restrict its use as an industrial chemical. 2.1 Final regulatory action (see Annex 2 for further details) Canada: Regulations that prohibit the manufacture, use, sale, offer for sale or import of PFOA and products containing PFOA, with a limited number of exemptions. (UNEP/FAO/RC/CRC.14/8 Sections 2 and 2.2.1 of the Canadian notification). Reason: Environment Norway: Regulations to restrict the production, import, export or sale of consumer products that contain PFOA, its salts and esters in consumer products if they exceed certain limit values. (UNEP/FAO/RC/CRC.14/8 Sections 2 and 2.2.1 of the Norwegian notification). Reason: Human health and the environment 2.2 Risk evaluation (see Annex 1 for further details) Canada: An ecological screening assessment was undertaken on perfluorooctanoic acid (PFOA), its salts and its precursors containing the perfluorinated alkyl moiety (C7F15, C8F17) and is directly bound to any chemical moiety other than a fluorine, chlorine or bromine atom. Once in the environment, PFOA is extremely persistent and not known to undergo significant abiotic or biotic degradation under relevant environmental conditions. PFOA is highly soluble in water and typically present as an anion (conjugate base) in solution. It has low vapour pressure; therefore, the aquatic environment is expected to be its primary sink, with some additional partitioning to sediment. The presence of PFOA in the Canadian Arctic is likely attributable to the long-range transport of PFOA (e.g., via ocean currents) and/or volatile precursors to PFOA (e.g., via atmospheric transport). 7 PFOA has been detected at trace levels in the northern hemisphere. In North America, higher levels were measured in surface waters in the vicinity of US fluoropolymer manufacturing facilities (<0.025–1900 μg/L) and in groundwater near US military bases (not detected [ND] to 6570 μg/L). PFOA was detected in effluent from Canadian wastewater treatment facilities at concentrations ranging from 0.007 to 0.055 μg/L. PFOA was also detected in the influent at US wastewater treatment facilities at concentrations ranging from 0.0074–0.089 μg/L. Trace levels of PFOA have been measured in Canadian freshwater (ND–11.3 μg/L) and freshwater sediments (0.3– 7.5 μg/kg). PFOA has also been detected in a variety of Canadian biota (ND–90 µg/kg wet weight [kg-wwt] tissue) in southern Ontario and the Canadian Arctic. The highest concentration of PFOA in Canadian organisms was found in the benthic invertebrate Diporeia hoyi at 90 µg/kg-wwt, followed by turbot liver at 26.5 µg/kg-wwt, polar bear liver at 13 µg/kg-wwt, caribou liver at 12.2 µg/kg-wwt, ringed seal liver at 8.7 µg/kg-wwt and walrus liver at 5.8 µg/kg-wwt. Following an accidental release of fire-fighting foam in Etobicoke Creek (Ontario), PFOA was measured in common shiner liver at a maximum concentration of 91 µg/kg-wwt. However, at the time of the assessment in 2012, PFOA concentrations in Canadian biota (tissue specific and whole body) were below the highest concentration found in US biota (up to 1934.5 µg/kg-wwt in gar liver). Temporal or spatial trends in PFOA concentrations in guillemot eggs, lake trout, thick-billed murres, northern fulmars or ringed seals could not be determined at the time of assessment. However, temporal trends were found for PFOA concentrations in polar bears (1972 – 2002 and 1984 – 2006) and sea otters (1992 – 2002). PFOA doubling time in liver tissue was calculated to be 7.3 ± 2.8 years for Baffin Island polar bears and 13.9 ± 14.2 years for Barrow, Alaska, polar bears; central East Greenland polar bears showed an annual increase of 2.3% in PFOA concentrations. Concentrations of PFOA also increased significantly over a 10-year period for adult female sea otters. Due to the perfluorination, the perfluorinated chains are both oleophobic and hydrophobic. PFOA primarily binds to albumin proteins in the blood of biota and, as a result, is present in blood and highly perfused tissues such as liver and kidney, rather than lipid tissue. There is experimental evidence indicating that PFOA is not highly bioaccumulative in fish. However, these results should not be extrapolated to non-aquatic species, since gills provide an additional mode of elimination for PFOA that air-breathing organisms, such as terrestrial and marine mammals, do not possess. Field studies indicating biomagnification factors greater than 1 for the Arctic and other mammals (such as narwhal, beluga, polar bear, walrus, bottlenose dolphins, and harbor seals) suggest that PFOA may bioaccumulate and biomagnify in terrestrial and marine mammals. Reported field biomagnification factors for terrestrial and marine mammals ranged from 0.03–31. Polar bears, as the apex predator in the Arctic marine food web, have been shown to be the most contaminated with PFOA relative to other Arctic terrestrial organisms. At the time of the assessment, the risk quotients for pelagic organisms indicated a low likelihood of risk from exposures at current concentrations in the aquatic environment. The risk quotient for Canadian mammalian wildlife (i.e., polar bears) is less than 1. However, due to the persistent nature of the substance, its tendency to accumulate and biomagnify in a variety of terrestrial and marine mammals, its hepatotoxicity, and the upward temporal trend of PFOA concentrations in polar bears and other species, it was concluded at the time of the assessment that PFOA concentrations in polar bears may approach exposures resulting in harm. The assessment was based on a weight of evidence approach regarding persistence, bioaccumulation, temporal trends in some species (i.e. the polar bear), long-range transport and the widespread occurrence and concentrations of PFOA in the environment and in biota (including remote areas of Canada). Based on the information presented in the screening assessment in 2012, it was concluded that PFOA, its salts and its precursors are entering or may be entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity. Norway: The notification and its supporting material provide a large amount of data relating to human exposure, as well as information from European Food and Safety Agency document “Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts: scientific opinion of the Panel on Contaminants in the Food Chain” and European Chemicals Agency document “Pentadecafluorooctanoic acid (PFOA) as a substance of very high concern because of its carcinogenic, mutagenic or toxic for reproduction (CMR) and persistent, bio-accumulating and toxic (PBT) properties”. The Norwegian studies show that PFOA is transferred from the mother to the fetus, and that relatively high plasma concentrations are detected in blood samples from small children. Information on occupational exposure of professional Norwegian ski-waxers, leading to higher PFOA concentrations in blood serum, is also provided. Information in the risk evaluation points to widespread occurrence and concentrations of PFOA in the Norwegian environment (air, water and sediment). Persistence, bioaccumulation, temporal trends in some Arctic species (e.g., the polar bear) and evidence of long-range transport warrant concern. 8 PFOA is a substance of very high concern with respect to its health and environmental properties. PFOA is harmful to the reproductive system, is carcinogenic, toxic and harmful to human health through repeated exposure, and is also an irritant. PFOA does not degrade in the environment. PFOA is a PBT substance. The notification concludes it is impossible to establish an acceptable level for substances with such properties in the environment, and that emissions and exposure should be limited to the greatest extent possible. 3. Protective measures that have been applied concerning the chemical 3.1 Regulatory measures to reduce exposure Canada: Perfluorooctanoic acid, which has the molecular formula C7F15CO2H, its salts, and its precursors (collectively referred to as PFOA) and products containing them are subject to the Prohibition of Certain Toxic Substances Regulations, 2012 [the Regulations], under the Canadian Environmental Protection Act, 1999 (CEPA). The Regulations prohibit the import, manufacture, use, sale and offer for sale of PFOA, and products containing PFOA, with a limited number of exemptions. The risk management objective for PFOA is to achieve the lowest level of releases into the Canadian environment which is technically or economically feasible. The prohibitions do not apply to any toxic substance that is: a) contained in a hazardous waste, hazardous recyclable material or non-hazardous waste to which Division 8 of Part 7 of CEPA applies; b) contained in a pest control product as defined in subsection 2(1) of the Pest Control Products Act; c) present as a contaminant in a chemical feedstock that is used in a process from which there are no releases of the toxic substance and on the condition that the toxic substance is destroyed or completely converted in that process to a substance that is not a toxic substance set out in either Schedule 1 or 2 of the regulations; or d) to be used in a laboratory for analysis, in scientific research or as a laboratory analytical standard. The Regulations do not prohibit: a) The import, manufacture, use, sale and offer for sale of PFOA or a product containing it, if PFOA is incidentally present [subsection 6(1) of the Regulations] b) The import, manufacture, use, sale and offer for sale of PFOA or a product containing them, before January 1, 2017, if it is designed for use in water-based inks or in photo media coatings, [paragraph 6(2)(b) of the Regulations] c) The import, use, sale and offer for sale of aqueous film forming foam for fire-fighting operations that contain PFOA [subsection 6(2.2) of the Regulations] d) The import, use, sale or offer for sale of manufactured items containing PFOA [subsection 6(2.4) of the Regulations] e) The use or import of products containing PFOA, if the product is for personal use [subsection 6(4) of the Regulations]. f) The use, sale or offer for sale of: a. Products containing PFOA if manufactured or imported before the Regulations come into force [paragraph 7(2)(a) of the Regulations] b. Water-based inks and photo media coatings containing PFOA that were manufactured or imported before January 1, 2017 [subsection 7(1) of the Regulations] c. PFOA or products containing it if they were manufactured or imported in accordance with a permit (section 8 of the Regulations). (UNEP/FAO/RC/CRC.14/8 Section 2.3.2 of the Canadian notification). Norway: Since 1 June 2014, it has been prohibited to manufacture, import, export, and sell consumer products that contain PFOA and individual salts and esters of PFOA (CAS Nos. 335-67-1, 3825-26-1, 335-95-5, 2395-00-8, 335-93-3, 335-66-0, 376-27-2, 3108-24-5), as pure substance or in 9 a mixture when the mixture contains 0.001 per cent or more by weight of the substance. Furthermore, from 1 June 2014, it has been prohibited to manufacture, import, export and sell textiles, carpets and other coated consumer products that contain PFOA (CAS Nos. 335-67-1, 3825- 26-1, 335-95-5, 2395-00-8, 335-93-3, 335-66-0, 376-27-2, 3108-24-5), when the content of the substance in the product's individual parts is greater than or equal to 1 µg/m2. Additionally, from 1 June 2014, it has been prohibited to manufacture, import, export and sell consumer products that contain PFOA, when the content of the substance in the product's individual parts is greater than or equal to 0.1 weight percent. The prohibitions do not apply to food packaging, food contact materials, medical devices, or to spare parts for consumer products made available for sale prior to 1 June 2014. (UNEP/FAO/RC/CRC.14/8 Sections 2 and 2.2.1 of the Norwegian notification). 3.2 Other measures to reduce exposure An overview related to risk reduction approaches for PFASs was provided by OECD. The document includes information on existing risk reduction approaches in countries including voluntary risk reduction measures taken by corporations (see pp. 61 to 64 in OECD, 2015). National and/or regional regulations related to PFOA comprise the following: a) In 2013, the EU identified both PFOA and its ammonium salt (APFO) as Substances of Very High Concern (SVHC) due to their persistent, bioaccumulative and toxic properties, and PFOA and APFO were included into the REACH-Candidate List. On request industry is obliged to inform consumers on the occurrence to the listed substances in consumer articles if the SVHC in those articles is present in a concentration of more than 0.1 % (w/w). PFOA/APFO is restricted as a substance or in a mixture for the supply to consumers according to regulation (EU) 317/2014; b) PFOA has been included in Annex XVII (restriction) of the REACH regulation within the EU (Commission regulation (EU) 2017/1000 of 13 June 2017). PFOA shall not be manufactured or placed on the market as substances on their own from 4 July 2020, or be used in the production of, or placed on the market in another substance, as a constituent, a mixture, or an article, in a concentration equal to or above 25 ppb of PFOA including its salts or 1 000 ppb of one or a combination of PFOA-related substances. The restriction includes several exemptions; c) In the EU, PFOA was included in Annex VI of the Classification, Labelling and Packaging (CLP) Regulation (Regulation (EC) No 1272/2008), by the Commission Regulation (EU) No 944/2013 of 2 October 2013 (index number: 607-704-00-2); d) In the US, the United States Environment Protection Agency (USEPA) established the PFOA Stewardship Programme in 2006. This is a programme that included eight major OECD based manufacturers of PFOA, its salts and PFOA-related compounds (Arkema, Asahi, BASF, Clariant, Daikin, 3M/Dyneon, DuPont and Solvay Solexis). The programme was a voluntary initiative to the substantial phase-out the manufacture and use of PFOA, PFOA precursors and related higher homologue substances (USEPA, 2015). It was successfully completed at the end of 2015. On 21 January 2015, the USEPA proposed a Significant New Use Rule under the Toxic Substances Control Act (TSCA) to require manufacturers of PFOA and PFOA- related chemicals, including as part of articles, and processors of these chemicals to notify USEPA at least 90 days before starting or resuming new uses of these chemicals in any products. This notification would allow USEPA the opportunity to evaluate the new use and, if necessary, take action to prohibit or limit the activity.3 While in general, eligible polymers are exempted from the full USEPA new chemical premanufacture notice and review process, effective 26 January 2010 the USEPA rescinded the exemption for polymers containing as an integral part of their composition, except as impurities, certain perfluoroalkyl moieties consisting of a CF3- or longer chain length. This exclusion included polymers that contain any one or more of the following: perfluoroalkyl sulfonates (PFAS), perfluoroalkyl carboxylates (PFAC), fluorotelomers, or perfluoroalkyl moieties that are covalently bound to either a carbon or sulfur atom where the carbon or sulfur atom is an integral part of the polymer molecule; In China, several national actions were taken in 2011 to restrict new installations of PFOA production facilities, to eliminate PFOA-containing paints and fluoropolymers that use PFOA in the polymerization and to encourage the development of alternatives to PFOA. In 2013, fluoropolymer coatings for non-stick pans, kitchenware and food processing equipment that use PFOA in the polymerization were recognized as products with high pollution and high environmental risk in the Comprehensive Catalogue for 3 https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/and-polyfluoroalkyl-substances-pfass- under-tsca. 10 Environmental Protection. In January 2017, new technical requirements for textile products came into force, in particular establishing limits of PFOA levels to 0.05 mg/kg in coated infant textile products and to 0.1 mg/kg in all other coated textile products, respectively. (UNEP/POPS/POPRC.12/11/Add.2 section 2.3.2 of the POPRC Risk Profile) (UNEP/POPS/POPRC.13/7/Add.2, Chapter 1.4 and 1.5 of the POPRC Risk Management Evaluation) Stockholm Convention on Persistent Organic Pollutants Stockholm Convention POPs Review Committee has recommended to the Conference of the Parties that it consider listing perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds in Annex A to the Convention with specific exemptions (see UNEP/POPS/POPRC-14/2, UNEP/POPS/POPRC.14/6/Add.2). 3.3 Alternatives It is essential that before a country considers substituting alternatives, it ensures that the use is relevant to its national needs, and the anticipated local conditions of use. The hazards of the substitute materials and the controls needed for safe use should also be evaluated. Canada: In Canada, manufacturing has been the main industrial sector using PFOA, specifically, paper and chemical manufacturing (note PFOA is not manufactured or imported in Canada; however, its salts and precursors have been reported to be imported). Elsewhere, PFOA has been used in the production of fluoropolymers and fluorotelomers and as additive and component in consumer and industrial products. In January 2006, the US EPA introduced a voluntary Stewardship Program to reduce facility emissions and product content of PFOA and related chemicals on a global basis and to work toward eliminating emissions and product content of these chemicals by 2015. This Stewardship Program has been a major driver for companies to reduce residuals in products and to switch from PFOA products to safer alternatives. The US EPA is also reviewing substitutes for PFOA, PFOS, and other long-chain perfluorinated substances as part of its review process for new chemicals under EPA's New Chemicals Program. Over 150 alternatives of various types have been received and reviewed by EPA. Under the US EPA's New Chemical Review of Alternatives for PFOA and Related Chemicals, shorter chain-length perfluorinated telomeric substances have been notified as alternatives for a variety of uses including, for example, textile, carpet and paper additive uses, and tile surface treatments. The major industry users in the global community are moving quickly to replace uses of C-8 and higher homologues. Substances which are new to Canada, including new substitutes for PFOA, are subject to the New Substances provisions of CEPA and the New Substances Notification Regulations. Any company intending to import or manufacture such a substance must submit a notification, with the substance undergoing an assessment by Environment Canada and Health Canada to determine whether it meets the definition of "toxic" set out in section 64 of CEPA. Many substitutes to PFOA have been notified to Environment Canada's New Substances Program. UNEP/FAO/RC/CRC.14/8 section 2.5.3.2 of the Canadian notification Norway: US EPA's review of alternatives to perfluorinated chemical substances has been ongoing since 2000 and is consistent with the approaches to alternatives encouraged under the 2010/15 PFOA Stewardship Program. Through June 2008, over 100 alternatives of various types have been received and reviewed by EPA. https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-and-polyfluoroalkyl- substances-pfass#tab-3 Additional information on alternatives could also be found in these two publications: OECD/UNEP Global PFC Group, 2013. Wang et al., 2013. UNEP/FAO/RC/CRC.14/8 section 2.5.3.2 of the Norwegian notification General: Several potential alternatives for use in textiles such as short-chain fluorinated alternatives, non-fluorine containing alternatives and non-chemical alternatives have been identified in the Risk Management Evaluation of perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds under the Stockholm Convention, including those that meet regulatory requirements and are in current use. Alternatives to PFOA for manufacture of polytetrafluoroethylene (PTFE) exist and have been commercialised. Non-fluorinated alternatives and the move to 11 digital imaging have successfully replaced PFOA in the imaging and printing industry. Alternatives to all uses of PFOA in fire-fighting foams exist and include fluorine-free solutions as well as fluorosurfactants with C6- fluorotelomers. Fluorine-free foams are comparable to fluorine-based AFFFs and fire-fighting foams with PFOA in their performance and in meeting relevant certifications for almost all uses. Based on current data, prices of fluorine- free and fluorine containing aqueous film-foaming foams (AFFFs) are comparable. Some concerns were expressed about the importance of effective fire-fighting foams for liquid fuel fires, the potential unavailability of suitable alternatives and the cost of their use and implementation, considering that some time to move to alternatives without PFASs may be needed. In the USA, non-fluorinated AFFF have been considered to meet the Federal performance standards and acceptable for use in airports in 2018 (FAA Reauthorization Act of 2018 (HR 302)). For more information, see chapter 4.2.3 of the POPRC Addendum to the Risk Management Evaluation UNEP/POPS/POPRC.14/6/Add.2 3.4 Socio-economic effects Canada: The scientific evidence has demonstrated that the substance PFOA and its salts are persistent and that they accumulate and biomagnify in terrestrial and marine animals. The ongoing release of PFOA may result in harm to the Canadian environment. The Regulations protect the Canadian environment by preventing the reintroduction of PFOA as industry is already working towards phasing out these substances. The Regulations were expected to have a low-cost impact on the industry. The substances were never manufactured in Canada and are only known to be imported within products or manufactured items. Furthermore, industry sectors have already completed the transition to alternatives, or were expected to do so prior to the coming into force of the Regulations. Development of alternatives to PFOA in water-based inks and photo media coatings were underway, and companies were expected to eliminate their use of these substances by the end of 2016, when the temporary exemption expired. For aqueous film-forming foams containing PFOA, which are allowed under the Regulations, the development of alternatives has begun and will be monitored. UNEP/FAO/RC/CRC.14/8 section 2.5.3.1 of the Canadian notification Norway: The regulation proposal may result in some increased costs but will result in significant reductions of the amount of PFOA introduced into the environment and it will reduce the risk of health and environmental damages. The benefits are therefore expected to outweigh the costs on the basis of the proposal’s anticipated positive effects for health and the environment. UNEP/FAO/RC/CRC.13/8 section 2.5.3.1 of the Norwegian notification 4. Hazards and Risks to human health and the environment 4.1 Hazard Classification WHO / IPCS Not available. IARC Possibly carcinogenic to humans (Group 2B). 12 European Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation) for Union PFOA (CAS 335-67-1) (https://echa.europa.eu/information-on-chemicals/cl-inventory-database/- /discli/details/67229 ): Acute Tox. 4 -H302 (Harmful if swallowed) -H332 (Harmful if inhaled) Eye Dam. 1 -H318 (Causes serious eye damage) Carc. 2 -H351 (Suspected of causing cancer) Lact. -H362 (May cause harm to breast-fed children) STOT RE 1 -H372 (liver) (Causes damage to organs (liver) through prolonged or repeated exposure) Repr. 1B -H360D (May damage the unborn child) Due to its PBT and CMR properties, PFOA and its ammonium salt (APFO) has been identified as substances of very high concern (SVHC) under REACH Regulation No 1907/2006 by unanimous agreement between EU Member States in July 2013. (UNEP/FAO/RC/CRC.14/8 section 3.1 of the Canadian and Norwegian notifications) US EPA Not available. 4.2 Exposure limits Dietary intake including water is considered as the most important route of human exposure to PFOA based on studies from various countries. Taking this into consideration, among others, the U.S. EPA has issued a lifetime drinking water Health Advisory for combined PFOA/PFOS of 0.07 micrograms per liter (μg/L) based on a reference dose (RfD) derived from a developmental toxicity study in mice. (UNEP/POPS/POPRC.12/11/Add.2 section 2.3.2 of the POPRC Risk Profile) The European Food and Safety Agency, in their scientific evaluation on the risks to human health related to the presence of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in food, derived a health-based guidance value that was based on human epidemiological studies. After benchmark modelling of serum levels of PFOS and PFOA, and estimating the corresponding daily intakes, the CONTAM Panel established a tolerable weekly intake (TWI) of 6 ng/kg bw per week for PFOA. Exposure of a considerable proportion of the population exceeds the proposed TWIs. http://www.efsa.europa.eu/en/efsajournal/pub/5194 https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2018.5194 Occupational exposure limits: MAK: (inhalable fraction): 0.005 mg/m3; peak limitation category: II(8); skin absorption (H); carcinogen category: 4; pregnancy risk group: C Source: International Chemical Safety Card (ICSC) 1613 German Biological Exposure Indices (BEI) 5 mg/l in serum http://gestis-en.itrust.de 4.3 Packaging and labelling The United Nations Committee of Experts on the Transportation of Dangerous Goods classifies the chemical in: 13 Hazard Class UN #3261 and Packing CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S. Group: UN Hazard Class: 8; UN Pack Group: III International UN #3261 Maritime CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S. Dangerous Goods (IMDG) Code Transport Transport Emergency Card: TEC (R)-80GC4-II+III Emergency Card 4.4 First aid NOTE: The following advice is based on information available from the World Health Organisation and the notifying countries and was correct at the time of publication. This advice is provided for information only and is not intended to supersede any national first aid protocols. Prevention First Aid Inhalation Use local exhaust or breathing Fresh air, rest. Artificial respiration may be needed. protection. Refer for medical attention. Skin Protective gloves. Protective clothing. Wear protective gloves when administering first aid. Remove contaminated clothes. Rinse and then wash skin with water and soap. Eyes Wear safety goggles or eye protection in Rinse with plenty of water for several minutes (remove combination with breathing protection if contact lenses if easily possible). Refer immediately for powder. medical attention. Ingestion Do not eat, drink, or smoke during work. Rinse mouth. Give one or two glasses of water to drink. Refer for medical attention http://www.inchem.org/documents/icsc/icsc/eics1613.htm International Chemical Safety Card (ICSC) 1613 4.5 Waste management DISPOSAL: Dispose of as hazardous waste in compliance with local, regional and national regulations. Dispose of wastes in an approved waste disposal facility. Annexes Annex 1 Further information on the substance Annex 2 Details on final regulatory action reported Annex 3 Address of designated national authorities Annex 4 References 14 Annex 1 Further information on the substance Introductory text to Annex I The information presented in the present annex reflects the conclusions of the two notifying Parties, namely Canada and Norway. Where possible, information provided by these two Parties on hazards has been presented together, while the risk assessments, which are specific to the conditions prevailing in the Parties, are presented separately. This information is taken from the documents referenced in the notifications in support of the final regulatory actions relating to PFOA. The notification from Norway and Canada were first reported in PIC Circular XLI (41) in June 2015 and PIC Circular XLVII (47) in June 2018, respectively. The notification from Canada contained a non-exhaustive list of PFOA, its salts and precursors in Annex A. The notification from Norway specified eight CAS-numbers. The information below refers to perfluorooctanoic acid. 15 Annex 1 – Further information on notified chemical 1 Identity and Physico-Chemical properties 1.1 Identity Octanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro- (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 1.2 Formula C8HF15O2 (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 1.3 Colour and Texture Solid (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 1.4 Decomposition temperature Decomposes on heating above 300°C (ICSC 1613) 1.6 Density (g/cm3) Not available. 1.7 Resistance to acids Not available. 1.8 Resistance to alkalis Not available. 1.9 Tensile strength (103 kg/cm2) Not available. 2 Toxicological properties 2.1 General 2.1.1 Mode of Action Data on the mode of action are insufficient (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 2.1.2 Symptoms of Not available. poisoning 2.1.3 Absorption, In humans, PFOA is well absorbed by all routes of exposure; it has not been distribution, demonstrated to be metabolized and has a relatively long half-life. Salts of PFOA excretion and are expected to dissociate in biological media to produce the perfluorooctanoate metabolism in (PFO) anion, and are therefore considered toxicologically equivalent to PFOA. Low mammals concentrations of PFOA have been identified in blood samples from non- occupationally exposed Canadians, including newborns, indicating environmental exposure to PFOA and/or compounds that can degrade to PFOA. Canadians are also potentially exposed to PFOA in utero and through lactational transfer. The relative contributions of PFOA and its salts and precursors to total PFOA exposure were not characterized; rather the focus was on aggregate exposure to the moiety of toxicological concern, PFOA. (UNEP/FAO/RC/CRC.14/8 Canadian notification) PFOA is efficiently taken-up by mammals from all exposure routes, and is not readily eliminated. In humans, half-life is estimated to 2.3 years, but even longer half-life has been estimated for retired workers from a perfluoroalkyl manufacturing plant with high plasma PFOA levels. In contrast, half-life values for the monkey, rat, and mouse are 20.8 days, 11.5 days, and 15.6 days, respectively. PFOA is transferred to the fetus where it accumulates in the liver, it is also transferred to the child via breast milk. Perfluorinated chemicals (PFCs) are amphiphilic. They bind to serum proteins and proteins in cell membranes, and accumulate in the blood and internal organs such as liver, kidneys, testes and brain. Metabolic transformation seems to be less important for elimination. Urine is the primary route of excretion and there are large sex and species differences in the excretion of PFOA. The reason for the differences in elimination is likely that PFOA is a substrate for renal organic anion transporters, regulating active renal reabsorption, and these transporters are differentially expressed between species and sex. (UNEP/FAO/RC/CRC.14/8 Norwegian notification) PFOA is readily absorbed after exposure (ingestion) and accumulates in serum and highly perfused organs, mainly in the liver and kidney, due to PFOA primarily 16 binding to albumin proteins in the blood. There is evidence that PFOA levels in humans accumulate and increase with age. PFOA does not undergo metabolism or biotransformation in the body. As mentioned earlier, the half-life of PFOA elimination in humans is long, ranging between 2 and 4 years. PFOA is known to be transmitted to the fetus in cord blood and to the newborn in breast milk. Developing fetuses and newborns are particularly sensitive to PFOA- induced toxicity. Positive correlation in PFOA level between maternal and cord blood samples has been reported in several birth cohort studies in Spain and Norway. As PFOA can be transferred to infants through breast-feeding, the ECHA’s Risk Assessment Committee (RAC) agreed on an additional classification of PFOA on lactation effects (CLP: Lact. H362: May cause harm to breast-fed children). (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 2.2 Toxicology The toxicity of PFOA has been evaluated by ECHA, US EPA, the Canadian studies ministries and EFSA. In the European Union, PFOA has a legally-binding harmonized classification as Carc. 2, Repr. 1B and STOT RE 1 (liver) according to Regulation (EU) No 944/2013. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation) for PFOA (CAS 335-67-1) (https://echa.europa.eu/information-on- chemicals/cl-inventory-database/-/discli/details/67229 ): Acute Tox. 4 -H302 (Harmful if swallowed) -H332 (Harmful if inhaled) 2.2.1 Acute toxicity Toxicity studies in laboratory animals were used to determine the critical effects and associated serum levels of PFOA. Following oral dosing of PFOA ammonium salt (APFO), increased liver weight in mice and altered lipid parameters in rats were observed in short-term (14-day) toxicity studies; increased liver weight was noted in a 26-week toxicity study in monkeys; and increased liver weight in dams, alterations in fetal ossification and early puberty in male pups were found in a developmental toxicity study in mice. (UNEP/FAO/RC/CRC.14/8 Canadian notification) PFOA exhibits moderate acute, oral and inhalation toxicity (UNEP/FAO/RC/CRC.14/8 Norwegian notification) 2.2.2 Short term In sub-acute and chronic studies, PFOA affected primarily the liver and can toxicity cause developmental and reproductive toxic effects at relatively low dose levels in experimental animals. Twenty-eight day oral toxicity studies in rats and mice showed mortality and dose-related reduced weight gain and increased liver weight at PFOA dietary concentrations of 30 mg/kg and higher or drinking water concentrations of 50 mg/L and above. (UNEP/FAO/RC/CRC.14/8 Norwegian notification) 2.2.3 Genotoxicity PFOA has not been shown to be mutagen. The negative outcome in a (including comprehensive series of in vitro and in vivo short-term tests at gene and/or mutagenicity) chromosome level indicates that PFOA is devoid of significant genotoxic activity. (UNEP/FAO/RC/CRC.14/8 Norwegian notification) 2.2.4 Long term PFOA increased the tumour incidence in rats, mainly in the liver. Based on the toxicity and weight of evidence at present, the carcinogenic effects in rats appear to be due to carcinogenicity indirect/non-genotoxic modes of action. PFOA has been shown to induce hepatocellular adenomas, Leydig cell adenomas and pancreatic acinar cell hyperplasia in male rats. (UNEP/FAO/RC/CRC.14/8 Norwegian notification) In 2-year carcinogenicity bioassays in rats, males administered a high dose of APFO in the diet had significantly higher incidences of adenomas of the liver hepatocytes, 17 Leydig cells in the testes and pancreatic acinar cells. No evidence of carcinogenic activity was seen in the female rats. Liver tumours in male rats may be induced via liver toxicity resulting from PFOA-induced peroxisome proliferation, and additional pathways secondary to peroxisome proliferation may be involved in the generation of tumours at other sites. As primates are much less susceptible than rodents to peroxisome proliferation, the PFOA-induced tumours in male rats are considered to have little or no relevance for humans. Although blood levels of PFOA were not determined in the chronic studies, the oral dose of APFO was several times higher than those in the critical short-term and subchronic studies. Although there is some evidence to suggest that PFOA may be capable of causing indirect oxidative DNA damage, the genotoxicity database indicates that PFOA is not mutagenic. Thus, as the tumours observed in male rats are not considered to have resulted from direct interaction with genetic material, a threshold approach is used to assess risk to human health. (UNEP/FAO/RC/CRC.14/8 Canadian notification) Animal studies have demonstrated the induction of tumours mediated by PFOA or APFO, and hepatic activation of the peroxisome proliferator-activated receptor α (PPARα) has been proposed as a mechanism of induction of hepatic tumours. However, the PPAR-agonist mode of action proposed for rat liver, testes and pancreatic tumours may not be relevant for humans. However, human relevance had not been definitively determined according to established frameworks a decade ago, and PFOA compounds have also not been tested for carcinogenic potential in any laboratory animal species other than rats. Therefore, the RAC came to the conclusion that data on the mode of action are insufficient to conclude that APFO- induced tumours in animals are not relevant for humans, and therefore, PFOA is classified as Carc 2. Based on limited evidence in humans that PFOA causes testicular and renal cancer as well as limited evidence in experimental animals, IARC has classified PFOA as a Group 2B substance (possibly carcinogenic to humans). (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) Findings from studies seem to indicate a PFOA-mediated effect on the endocrine system. Prenatal exposure of PFOA may alter testosterone concentrations in females, and an inverse correlation between parathyroid hormone 2 receptor (PTH2R) and PFOA exposure was also reported in a study of 189 women. As for men, a study reported an inverse relationship between PFOA serum level in men and expression of nuclear receptors such as estrogen and androgen receptors. Also, early menopause in women with high PFOA levels has been observed in the C8 Health Project. PFOA has been implicated to act as a so-called obesogene similar to other endocrine disruptive compounds that can act directly on ligands for nuclear hormone receptors or affect components in metabolic signaling pathways. A human prospective cohort study showed a correlation between low dose PFOA exposure of 655 Danish pregnant women and obesogenic effects in their offspring at 20 years of age. Maternal PFOA concentrations were positively associated with serum insulin and leptin levels and inversely associated with adiponectin levels in female offspring. On the other hand, the C8 Health Project concluded that PFOA exposure in early life was not associated with overweight and obesity risk in adulthood. Evidence from several epidemiological studies seems to suggest an association between exposure to PFOA and changes in different thyroid hormones leading to altered thyroid function inducing thyroid disease such as hypothyroidism or hyperthyroidism. However, there have also been studies that reported inconsistent findings between PFOA exposure and thyroid diseases (i.e. inverse relation between subclinical hyperthyroidism and PFOA or no association between hypothyroidism and PFOA). The potential of PFOA to affect estrogen receptor (ER) and androgen receptor (AR) transactivity as well as aromatase enzyme activity was analysed in an in vitro study, and it was shown that PFOA significantly induced ER transactivity yet antagonized AR activity in a concentration-dependent manner. In addition, when PFOA was mixed with 6 other PFCs, a mixture effect more than additive was observed on AR 18 function, emphasizing the importance of considering the combined action of PFCs in assessing related health risks. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 2.2.5 Effects on PFOA has been shown to cause developmental and reproductive toxic effects at reproduction relatively low dose levels in experimental animals. Several studies observed complete litter loss at doses of 5 mg/kg bw/day. Increased postnatal pup mortality, decreased pup body weight and delayed sexual maturation were observed in several mice studies. A two generation reproductive toxicity study in rats has shown post- weaning mortality, reduced growth, and delayed sexual maturation. Follow-up developmental toxicity studies in mice have shown a pattern of neonatal mortality similar to that observed in mice; this consists of a dose-related increase in mortality during the first several days after birth. Cross-fostering studies have shown that the critical period of exposure is during the prenatal period. Further studies have shown delayed development of the mammary glands in both the dams and female offspring with systemic toxicity in rodents and monkeys following long-term exposure by the oral route. (UNEP/FAO/RC/CRC.14/8, Norwegian notification) 2.2.6 Neurotoxicity/ Impaired neurodevelopment has been associated with PFOA. An inverse delayed relationship between prenatal PFOA concentrations in mothers and neurotoxicity, neurodevelopment as determined with the mental development index (MDI) in Special studies female (not male) offspring at 6 months of age was observed in a Japanese birth where available cohort (Hokkaido) study. However, this relationship was not observed with offspring at 18 months of age. Also, no correlation between PFOA levels and birth weight was observed in the same cohort study. Statistically significant inverse associations between PFOA and memory impairment has been reported. On the other hand, there are studies that reported no association between PFOA exposure and impaired neurodevelopment or behavior. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 2.2.7 Summary of PFOA is classified as Carc. 2, Repr. 1B and STOT RE 1 (liver) according to mammalian Regulation (EU) No 944/2013. IARC also categorised PFOA as a Group 2B toxicity and substance (possibly carcinogenic to humans). There have been reported adverse overall health effects such as elevated cholesterol levels, altered evaluation reproductive/developmental effects, endocrine disruption, impaired neurodevelopment, as well as increased risk of cancer associated with PFOA exposure in humans. Scientific data have demonstrated PFOA-mediated immunotoxicity, primarily suppression of antibody response, in humans. Although the findings are limited, the reported adverse health effects suggest additional public health concerns. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 3 Human exposure/Risk evaluation 3.1 Food Human exposure typically takes place “human via environment” by consumption of drinking water and food, via uptake of contaminated indoor dust or from consumer products containing PFOA and its related substances. PFOA has been detected in humans in blood and breast milk from various countries. Babies are susceptible to PFOA exposure via breastfeeding or trans-placental passage, and people who live near fluoropolymer manufacturing facilities have been shown to have higher levels of serum PFOA than those from the general population. The available data indicate that Canadians are exposed to PFOA and its precursors in the environment, including via air, drinking water and food; and from the use of consumer products, such as new non-stick cookware and perfluorinated compound (PFC)-treated apparel and household materials such as carpets and upholstery. (UNEP/FAO/RC/CRC.14/8, Canadian notification) 3.2 Air PFOA has been detected in the air of remote areas (UNEP/POPS/POPRC.12/11/Add.2), as well as household dust (Shoeib et al., 2011) and airborne particulate matter (Yu et al., 2018). 19 3.3 Water Human PFOA exposure occurs via dietary intake of food and drinking water, exposure to contaminated indoor dust or consumer products containing PFOA and its related substances. Studies have demonstrated the presence of PFOA within humans, mainly in blood and breast milk samples. Fetuses and newborns are susceptible to PFOA exposure via breastfeeding or trans-placental passage. Occupational exposure or exposure near sites of production resulted in higher serum PFOA levels than exposure of general population. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 3.4 Occupational There are a few reports of detected PFOA serum levels in the occupationally exposure exposed workers. Indoor dust and total suspended particles seem to be important occupational exposure routes in fluorochemical manufacturing and is also considered relevant in domestic settings. In some cases, elevated serum PFOA levels can be largely attributed to exposure to PFOA-related compounds such as 8:2 FTOH. Persons living in the vicinity of fluorochemical manufacturing plants have higher PFOA levels than the general population. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 3.5 Medical data Not available. contributing to regulatory decision 3.6 Public exposure Analysis of serum samples demonstrate that PFOA is detectable across the general population in various countries. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 3.7 Summary- The Norwegian notification and its supporting material provide a large amount of overall risk data relating to human exposure, as well as information from European Food and evaluation Safety Agency document “Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts: scientific opinion of the Panel on Contaminants in the Food Chain” and European Chemicals Agency document “Pentadecafluorooctanoic acid (PFOA) as a substance of very high concern because of its CMR and PBT properties”. The Norwegian studies show that PFOA is transferred from the mother to the fetus, and that relatively high plasma concentrations are detected in blood samples from small children. Information on occupational exposure of professional Norwegian ski-waxers, leading to higher PFOA concentrations in blood serum, is also provided. Information in the risk evaluation points to widespread occurrence and concentrations of PFOA in the Norwegian environment (air, water and sediment). Persistence, bioaccumulation, temporal trends in some Arctic species (e.g., the polar bear) and evidence of long-range transport warrant concern. PFOA is a substance of very high concern with respect to its health and environmental properties. PFOA is harmful to the reproductive system, is carcinogenic, toxic and harmful to human health through repeated exposure, and is also an irritant. PFOA does not degrade in the environment. PFOA is a persistent, bio-accumulating and toxic (PBT) substance. The notification concludes it is impossible to establish an acceptable level for substances with such properties in the environment, and that emissions and exposure should be limited to the greatest extent possible. (UNEP/FAO/RC/CRC.14/8, Norwegian notification) 4 Environmental fate and effects 4.1 Fate Once in the environment, PFOA is extremely persistent and not known to undergo significant abiotic or biotic degradation under relevant environmental conditions. (UNEP/FAO/RC/CRC.14/8, Canadian notification) 4.1.1 Soil Based on high persistence, it was not possible to calculate half-lives in soil or sediment. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 20 4.1.2 Water PFOA is highly soluble in water and typically present as an anion (conjugate base) in solution. It has low vapour pressure; therefore, the aquatic environment is expected to be its primary sink, with some additional partitioning to sediment. (UNEP/FAO/RC/CRC.14/8, Canadian notification) 4.1.3 Air On the basis of the available data, abiotic degradation of PFOA in the atmosphere is expected to be slow. The atmospheric lifetime of PFOA has been predicted to be 130 days (conclusion by analogy from short-chain perfluorinated acids). (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 4.1.4 Bioconcentration PFOA does not seem to bio-concentrate in water-breathing animals. The high water solubility of PFOA enables fish to quickly excrete this substance via gill permeation, facilitated by the high water throughput. In air-breathing animals, PFOA has been found in terrestrial species as well as in endangered species as polar bear and in animals that may become endangered in near future (such as narwhal and beluga whale). Once taken up in the body, PFOA tends to partition to liver and blood. BMFs range from 1.3 – 125 for selected predator prey relationship TMFs range from 1.1 – 13 for selected food chains. (UNEP/FAO/RC/CRC.14/8, Norwegian notification) The assessment of bioaccumulation for PFOA is complicated by its physical properties, which make assessment of log Kow, BCF and BAF approaches challenging. PFOA does not accumulate in water-breathing animals according to the criteria of the Stockholm Convention. This can be explained by the way that fish process and excrete PFOA through their gills. PFOA biomagnifies in air breathing mammals. PFOA has been detected within the body tissues of air-breathing aquatic species. For terrestrial species, the presence of PFOA is readily detected, with a number of studies indicating BMF and TMF scores of greater than 1. There is evidence that PFOA bioaccumulates in air- breathing mammals and other terrestrial species, including humans. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 4.1.5 Persistence PFOA is extremely stable within the natural environment due to its chemical properties and does not degrade under environmentally relevant conditions. Based on the available experimental evidence it is concluded that PFOA is highly persistent in all environmental compartments, with a strong resistance to all conventional mechanisms of degradation under relevant environmental conditions. Within the aquatic compartment under natural environmental conditions, PFOA has a half-life of greater than 92 years with the most likely value of 235 years and shows no obvious decay from photodegradation. In aquatic environments where PFOA undergoes indirect photolysis, the half-life was estimated to be longer than 349 days. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 4.2 Effects on non- target organisms 4.2.1 Terrestrial The potential impact of exposure to perfluorinated compounds on liver lesions was vertebrates investigated in East Greenland polar bears. Liver parameters examined included mononuclear cell infiltrations, lipid granulomas, steatosis, Ito cells and bile duct hyperplasia/portal fibrosis. The population consisted of 28 females and 29 males harvested by local hunters between 1999 and 2002. Liver samples were analyzed for PFOS, perfluorononanoic acid, perfluoroundecanoic acid, perfluorodecanoic acid, perfluorotetradecanoic acid, PFOA, perfluorooctanesulfonamide, perfluorodecanoate and perfluorohexanesulfonate. In 23 cases, the concentration of PFOA was below the detection limit (0.0012 µg/g-wwt). Liver samples were also analyzed for several perfluorinated compound including C9, C10, C11, C12 and C13 PFCAs. Sixty-five percent of the polar bears had total PFA concentrations above 1 µg/g-wwt. In female bears, the total PFAS concentration ranged from 0.256 to 2.77 µg/g-wwt; in male bears, the total PFAS concentration ranged from 21 0.114 to 3.052 µg/g-wwt. All PFAS compounds in the analysis were summed, so a direct cause–effect correlation with a particular perfluorinated compound, such as PFOA, cannot be determined. East Greenland polar bears are also contaminated with other substances, such as organochlorines (polychlorinated biphenyls [PCBs], dichlorodiphenyltrichloroethane [DDT]) and mercury, which may function as confounding synergistic co-factors in the development of the lesions. The authors concluded that the statistical analysis did not answer the question of whether chronic exposure to perfluorinated compounds is associated with liver lesions in polar bears; however, these lesions were similar to those produced by perfluorinated compounds under laboratory conditions. (UNEP/FAO/RC/CRC.14/8, Canadian notification) There is experimental evidence in terrestrial organisms showing the potential for PFOA to induce alterations to the liver, endocrine dysfunction, developmental toxicity and tumour formation. Adverse effects include alterations in sexual maturation and pubertal timing, changes in mammary gland development as well as induction of a variety of tumours. There are some indications of PFOA-mediated immunomodulation. Because of the tendency of PFOA to bioaccumulate, PFOA concentrations in polar bears might increase over time and approach exposures resulting in harm. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 4.2.2 Aquatic species In traditional toxicity studies, PFOA exhibits moderate to low acute toxicities in pelagic organisms, including fish (70–2470 mg/L). PFOA exhibits low chronic toxicities in benthic organisms (>100 mg/L). There is one study on the toxicity of PFOA and its salts in avian wildlife. In this study, PFOA was found to have no effect on embryonic pipping success for white leghorn chickens at concentrations up to 10 µg/g of embryos. However, PFOA accumulated in the liver of these embryos to concentrations 2.9 – 4.5 times greater than the initial whole-egg concentration. A study examined freshwater male tilapia (Oreochromis niloticus) as the in vitro model to detect the induction of vitellogenin. Vitellogenin is an egg yolk precursor protein expressed in females of fish, amphibians, reptiles (including birds), insects and the platypus. In the presence of substances that affect endocrine function, males can also express the vitellogenin gene. Cultured male tilapia hepatocytes were exposed to PFOA, 4:2 FTOH, 6:2 FTOH and 8:2 FTOH for 48 hours. A dose- dependent induction of vitellogenin was observed in PFOA- and 6:2 FTOH–treated cells, whereas vitellogenin remained unchanged for 4:2 FTOH and 8:2 FTOH. The estimated 48-hour median effective concentration (EC50) values were 2.9 × 10 –5 M (12 mg/L) for PFOA and 2.8 × 10–5 M (12.9 mg/L) for 6:2 FTOH. In the time course study, vitellogenin induction took place at 48 hours (PFOA), 72 hours (4:2 FTOH), 12 hours (6:2 FTOH) and 72 hours (8:2 FTOH) and increased further after 96 hours of exposure. Co-exposure to a mixture of individual perfluorinated compounds and 17β-estradiol for 48 hours significantly inhibited 17β-estradiol- induced hepatocellular vitellogenin production in a dose-dependent manner, except for 4:2 FTOH. The estimated 48-hour median inhibitory concentration (IC50) values were 5.1 × 10–7 M(0.21 mg/L) for PFOA, 1.1 × 10–6 M (0.51 mg/L) for 6:2 FTOH and 7.5 × 10–7 M (0.35 mg/L) for 8:2 FTOH. In order to further investigate the estrogenic mechanism, the hepatocytes were co-exposed to a mixture of PFOA and 6:2 FTOH plus the known estrogen receptor inhibitor tamoxifen for 48 hours. The overall results demonstrated that PFOA and FTOHs have estrogenic activities and that exposure to a combination of 17β-estradiol and PFOA or FTOHs produces anti-estrogenic effects. The results of the estrogen receptor inhibition assay further suggested that the estrogenic effect of PFOA and FTOHs may be mediated by the estrogen receptor pathway in primary cultured tilapia hepatocytes. A study assessed the effects of PFOA on male and female rare minnows (Gobiocypris rarus) at concentrations of 3, 10 and 30 mg/L for 28 days. Exposure to PFOA at 3 mg/L elicited moderate hepatocellular hypertrophy in the livers of both male and female fish. Male rare minnows exposed to PFOA at 10 mg/L showed eosinophilic hyaline droplets in the cytoplasm of the hepatocytes; female rare minnows displayed more eosinophilic hyaline droplets in the cytoplasm of the hepatocytes, hepatocellular hypertrophy and vacuolar degeneration. Rare minnows exposed to PFOA at 30 22 mg/L showed severe hepatic histopathological changes and disruption of mitochondrial functions. The inhibition of the thyroid hormone biosynthesis genes and the induction of estrogen-responsive genes may indicate a role in endocrine function. Another study further identified the potential protein biomarkers for PFOA exposure in the livers of the rare minnows at 3, 10 and 30 mg/L for 28 days, finding the abundance of 34 and 48 protein spots altered in males and females, respectively. These proteins were involved in intracellular fatty acid transport, oxidative stress, macromolecule catabolism, the cell cycle, maintenance of intracellular Ca2+ homeostasis and mitochondrial function. In another article, the authors studied the in vivo effects of waterborne PFOA on the expression of hepatic estrogen-responsive genes, vitellogenin, and estrogen receptor and on the gonadal development in freshwater rare minnow (Gobiocypris rarus). The study showed mature females exposed to 3, 10, and 30 mg/L PFOA for 28 days had degenerating vitellogenic-stage oocytes (atresia) in the ovaries. In males exposed to 10 mg/L PFOA, primary growth–stage oocytes (pre-vitellogenic oocytes) developed in some testes. The number of sperm and various stages of germ cells within the spermatogenic cycle in the 10 and 30 mg/L PFOA treatments were lower than those in control males. PFOA increased hepatic vitellogenin concentration and induced testis-ova gonads in mature male rare minnows at 10 and 30 mg/L for 28 days. It was shown that PFOA can disrupt the activity of estrogen by inducing hepatic estrogen-responsive genes in males, although the mechanism of development of testes-ova in rare minnows by PFOA exposure is not known. The toxicity of PFOA was examined with respect to the multixenobiotic resistance mechanism in the marine mussel, Mytilus californianus. This mechanism acts as a cellular first line of defence against broad classes of xenobiotics exporting moderately hydrophobic chemicals from cells via adenosine triphosphate (ATP)– dependent, transmembrane transport proteins. The most studied transporter is the P- glycoprotein, which is a fragile defence mechanism and can be compromised by some xenobiotics. This increased sensitivity, referred to as chemosensitization, arises from the ability of the P-glycoprotein to recognize and bind to multiple xenobiotic substrates, resulting in the saturation of the binding capacity. Non-toxic substances can also be chemosensitizers and cause adverse effects on organisms by allowing normally excluded toxic substances to accumulate in the cell. PFOA at 50 µM (20 mg/L) was found to significantly inhibit the P-glycoprotein in Mytilus californianus and thus is a chemosensitizer for that organism. The study also showed that this inhibition was reversible once the marine mussel was removed from contamination and placed in clean seawater. The effect of PFOA on immune function and clinical blood parameters has been examined in bottlenose dolphins and sea turtles from Florida, Georgia and South Carolina. It should be noted that a direct cause–effect relationship cannot be clearly established, as there may be other co-occurring contaminants. The results revealed that there may be increases in indicators of inflammation and immunity in bottlenose dolphin blood parameters in relation to PFOA, suggesting that PFOA may alter biomarkers of health in marine mammals. Examples of biomarkers analyzed in bottlenose dolphins include absolute numbers of lymphocytes, serum triglyceride, serum total protein, serum albumin, serum cortisol, C-reactive protein, lysozyme activity and B-cell proliferation. Serum triglyceride exhibited stronger relationships to PFOA in females than in males. Lipopolysaccharide-induced lymphocyte proliferation (B-cell proliferation) had positive but weak correlations with PFOA in male bottlenose dolphins, and a strong correlation was observed between PFOA and lysozyme activity (a measurement of innate immunity) in the same species. However, in another study, no correlations were found between any perfluorinated compound, including PFOA, and blood chemistry parameters (e.g. cholesterol, creatinine, albumin, total serum ion etc.) for the northern fur seal (Callorhinus ursinus). Low levels of PFAs may also alter biomarkers of health in loggerhead sea turtles. Examples of biomarkers analyzed in loggerhead sea turtles include plasma total protein, plasma globulin, T-cell proliferation, plasma lysozyme activity and B-cell proliferation. (UNEP/FAO/RC/CRC.14/8, Canadian notification) 23 Acute aquatic toxicity is low in standard ecotoxicity tests; moderate to low acute toxicities are seen in pelagic organisms including fish and low chronic toxicities in benthic organisms. Adverse effects include intergenerational toxicity in the first offspring generation and some PFOA-mediated toxicity in freshwater algae and other aquatic organisms. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile) 4.2.3 Honeybees and Not available. other arthropods 4.2.4 Earthworms Not available. 4.2.5 Soil The soil-dwelling nematode Caenorhabditis elegans has been shown to be a microorganisms suitable test organism, showing both lethal and sublethal effects, in the ecotoxicological assessments of liquid and soil media. Acute lethal toxicity and multigenerational sublethal toxicity (fecundity and reproduction) were examined using PFOA concentrations of 0, 0.01 mM (4.14 mg/L), 0.1 mM (41.4 mg/L), 0.5 mM (207 mg/L), 1.0 mM (414.07 mg/L) and 5.0 mM (2100 mg/L) for 48 hours. All concentrations up to 0.1 mM (41.4 mg/L) showed no acute lethality until 48 hours. Acute lethality appeared at concentrations greater than 0.5 mM (207 mg/L) and did not depend on the incubation time. EC50s were calculated for 1 hour (3.85 mM or 1590 mg/L), 2 hours (2.80 mM or 1160 mg/L), 3 hours (2.70 mM or 1120 mg/L), 4 hours (2.65 mM or 1100 mg/L), 24 hours (2.75 mM or 1140 mg/L) and 48 hours (2.35 mM or 973 mg/L). In the multi-generational test, generation–response and concentration–response relationships were not observed for PFOA. (Government of Canada, 2012a) 4.2.6 Terrestrial In seed germination and 5-day root elongation toxicity tests on lettuce (Lactuca plants sativa), cucumber (Cucumis sativus) and pakchoi (Brassica rapa chinensis), PFOA had no effect on cucumber seed germination, with both LC50 and NOEC values greater than 2000 mg/L. The LC50 and NOEC values for lettuce seed germination were 1734 and 1000 mg/L, respectively. The LC50 and NOEC values for pakchoi seed germination were 579 and 250 mg/L, respectively. The EC 50 for root elongation for the three species ranged from 263 to 1254 mg/L. PFOA almost completely inhibited lettuce and pakchoi root growth at or above 1000 mg/L. NOECs for root elongation for the three species ranged from <62.5 to 250 mg/L. In a study on the soil-to-plant carryover of a mixture of PFOA/PFOS on spring wheat, oats, potatoes, maize, and perennial ryegrass. Concentrations ranged from 0.25 to 50 mg/kg of PFOA/PFOS as an aqueous solution. PFOA concentrations were higher than PFOS in all plants except for potatoes with uptake/storage more intensive in the vegetative portion than the storage organ. Visible abnormalities were noted at concentrations > 10 mg/kg. At 25 – 50 mg/kg PFOA/PFOS, necrosis was observed in both oats and potatoes, a yellowing of the ryegrass leaves, and diminished growth for spring wheat. (Government of Canada, 2012a) In plants, PFOA can cause visible abnormalities and alter root growth. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile). 5 Environmental Exposure/Risk Evaluation 5.1 Terrestrial Temporal trends were found for PFOA concentrations in polar bears (1972 – 2002 vertebrates and 1984 – 2006) and sea otters (1992 – 2002). PFOA doubling time in liver tissue was calculated to be 7.3 ± 2.8 years for Baffin Island polar bears and 13.9 ± 14.2 years for Barrow, Alaska, polar bears; central East Greenland polar bears showed an annual increase of 2.3% in PFOA concentrations. Concentrations of PFOA also increased significantly over a 10-year period for adult female sea otters. The risk quotient for Canadian mammalian wildlife (i.e., polar bears) is less than 1; however, due to the persistence of the substance, its tendency to accumulate and biomagnify in a variety of terrestrial and marine mammals, its hepatotoxicity, and the upward temporal trend of PFOA concentrations in polar bears and some other species, PFOA concentrations in polar bears may approach exposures resulting in harm. The assessment is based on a weight of evidence approach regarding 24 persistence, bioaccumulation, temporal trends in some species (i.e. the polar bear), long-range transport and the widespread occurrence and concentrations of PFOA in the environment and in biota (including remote areas of Canada). Based on the information presented in the screening assessment, it is concluded that PFOA, its salts and its precursors are entering or may be entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity. (UNEP/FAO/RC/CRC.14/8, Canadian notification) The notification concludes it is impossible to establish an acceptable level for substances [like PFOA] with such properties in the environment, and that emissions and exposure should be limited to the greatest extent possible. (UNEP/FAO/RC/CRC.14/8, Norwegian notification) 5.2 Aquatic species Trace levels of PFOA have been measured in Canadian freshwater (ND–11.3 μg/L) and freshwater sediments (0.3–7.5 μg/kg). PFOA has also been detected in a variety of Canadian biota (ND–90 µg/kg wet weight [kg-ww] tissue) in southern Ontario and the Canadian Arctic. The risk quotients for pelagic organisms indicate a low likelihood of risk from exposures at current concentrations in the aquatic environment. (UNEP/FAO/RC/CRC.14/8, Canadian notification) The notification concludes it is impossible to establish an acceptable level for substances [like PFOA] with such properties in the environment, and that emissions and exposure should be limited to the greatest extent possible. (UNEP/FAO/RC/CRC.14/8, Norwegian notification) 5.3 Honey bees Not available. 5.4 Earthworms Not available. 5.5 Soil Not available. microorganisms 5.6 Summary – Based on the available experimental evidence, it is concluded that PFOA is highly overall risk stable and persistent within the natural environment. PFOA is unlikely to degrade evaluation under conditions present in the natural environment and has been shown to have long half-lives within the environment. Monitoring data show that PFOA in soil leaches over time and can be a long-term contamination source to underlying groundwater. PFOA has been found in marine, limnetic and terrestrial biota worldwide, and bioaccumulation of PFOA occurs across trophic levels. Assessment of bioaccumulation for PFOA is complicated by its physical properties as a surfactant, which make analysis for development of log Kow values not directly possible. PFOA accumulates and biomagnifies in air breathing animals and other terrestrial species including humans but not in water breathing animals as fish excrete PFOA through their gills. Monitoring of water, snow, air, sediment and biota at remote locations all detect the presence of PFOA. Equally, environmental modeling data and other information enable to conclude that PFOA meets the criterion for long range transport. PFOA exhibits adverse effects for both terrestrial and aquatic species. Ecotoxicity data indicate a low acute toxicity for aquatic organisms. There is also experimental evidence in terrestrial organisms showing the potential for PFOA to induce changes in liver function, endocrine function, development as well as immune responses, and induction of tumours has been shown in rats exposed to PFOA. The adverse effects of PFOA in biota have not yet been elucidated, but because of the tendency of PFOA to bioaccumulate, PFOA concentrations in biota, especially polar bears, might increase over time and approach exposures resulting in harm. (UNEP/POPS/POPRC.12/11/Add.2, POPRC Risk Profile Chapter 3) 25 Annex 2 – Details on final regulatory actions reported Country Name: Canada 1 Effective date(s) of December 23, 2016. entry into force of actions Reference to the Prohibition of Certain Toxic Substances Regulations, 2012 (SOR/2012-285), as regulatory amended, 2016 (SOR/2016-252) under the Canadian Environmental Protection Act, document 1999 (CEPA). http://www.gazette.gc.ca/rp-pr/p2/2016/2016-10-05/html/sor-dors252-eng.html 2 Succinct details of Perfluorooctanoic acid, which has the molecular formula C7F15CO2H, its salts, and its the final precursors (collectively referred to as PFOA) and products containing them are regulatory subject to the Prohibition of Certain Toxic Substances Regulations, 2012 (the action(s) Regulations) as amended in 2016, under the Canadian Environmental Protection Act, 1999 (CEPA). The Prohibition of Certain Toxic Substances Regulations, 2012 prohibit the import, manufacture, use, sale and offer for sale of PFOA, and products containing PFOA, with a limited number of exemptions. 3 Reasons for action The regulatory action was based on concerns related to the environment. 4 Basis for inclusion The regulatory action was taken to protect environment. The regulatory action was into Annex III based on a risk evaluation taking into account the prevailing conditions in Canada. The screening assessment, on which the regulatory action in based on and that was performed in Canada (http://www.ec.gc.ca/ese-ees/default.asp?lanq=En&n=370AB133-1) makes use of the extensive information on uses, releases and environmental levels of PFOA in Canada, including the Canadian Arctic. 4.1 Risk evaluation The assessment is based on a weight of evidence approach regarding persistence, bioaccumulation, temporal trends in some species (i.e. the polar bear), long-range transport and the widespread occurrence and concentrations of PFOA in the environment and in biota (including remote areas of Canada). Based on the information presented in the screening assessment, it is concluded that PFOA, its salts and its precursors are entering or may be entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity. (UNEP/FAO/RC/CRC.14/8 Canadian notification) 4.2 Criteria used Risk to environment. Relevance to other The notification states that, once in the environment, PFOA is extremely persistent States and Region and not known to undergo significant abiotic or biotic degradation under relevant environmental conditions. PFOA is highly soluble in water and typically present as an anion (conjugate base) in solution. It has low vapour pressure; therefore, the aquatic environment is expected to be its primary sink, with some additional partitioning to sediment. The presence of PFOA in the Canadian Arctic is likely attributable to the long-range transport of PFOA (e.g., via ocean currents) and/or volatile precursors to PFOA (e.g., via atmospheric transport). PFOA has been detected at trace levels in the northern hemisphere. The notification states that a number of countries and organizations (including the European Union, Norway, the United States of America, the Stockholm Convention on Persistent Organic Pollutants and the Protocol to the United Nations Economic Commission for Europe Convention on Long-Range Transboundary Air Pollution of 1979) either have put in place or are proposing management measures to control the manufacture, import, use and releases of perfluoroalkyl substances (PFAS) and manufactured products containing PFAS. 26 Given the hazards and long-range transport of this substance as described in the screening assessment on which the regulatory action is based, any state or region in which exposure or release is possible may find the regulatory action relevant. 5 Alternatives In January 2006, the US EPA introduced a voluntary Stewardship Program to reduce facility emissions and product content of PFOA and related chemicals on a global basis and to work toward eliminating emissions and product content of these chemicals by 2015. This Stewardship Program has been a major driver for companies to reduce residuals in products and to switch from PFOA products to safer alternatives. The US EPA is also reviewing substitutes for PFOA, PFOS, and other long-chain perfluorinated substances as part of its review process for new chemicals under EPA's New Chemicals Program. Over 150 alternatives of various types have been received and reviewed by EPA. Under the US EPA’s New Chemical Review of Alternatives for PFOA and Related Chemicals, shorter chain-length perfluorinated telomeric substances have been notified as alternatives for a variety of uses including, for example, textile, carpet and paper additive uses and tile surface treatments. The major industry users in the global community are moving quickly to replace uses of C-8 and higher homologues. (UNEP/FAO/RC/CRC.14/8 Canadian notification) 6 Waste The notifying Party did not provide information on waste management of PFOA or management articles containing it. 7 Other None. 27 Country Name: Norway 1 Effective date(s) of 1 June 2014 entry into force of actions Reference to the PFOA and its salts and esters are regulated by Chapter 2-32 of the Regulation related regulatory to restrictions of the manufacture, import and placing on the market of chemicals and document other products hazardous to the human health and the environment (Product Regulation). Act no. 922 of June 2004. 2 Succinct details of Regulations to restrict the production, import, export or sale of consumer products the final that contain PFOA, its salts and esters in consumer products if they exceed certain regulatory limit values. The prohibition om manufacture and export did not apply until 1 January action(s) 2016 to a) adhesives, foil and tape in semiconductors, and b) photographic coatings of film, paper and printing plate. The prohibition on import and sale did not apply until 1 January 2018 to products for which it could be documented that the manufacture took place prior to prohibitions in mentioned above came into force. 3 Reasons for action The regulatory action was based on concerns related to human health and the environment. 4 Basis for inclusion The final regulatory action was taken to protect human health and the environment. into Annex III The regulatory action was based on a risk evaluation taking into account the prevailing conditions in Norway. 4.1 Risk evaluation In the Norwegian “Evaluation of consequences of regulating PFOA and selected salts and esters of PFOA in consumer products”, the following concerns were put forward for the proposed regulation: PFOA is present in the blood of the general population, breast milk and in umbilical cord blood. PFOA is eliminated from the body very slowly. Humans are exposed to PFOA by consuming contaminated foods or water, by breathing air that is polluted as well as by ingesting dust. Fish is an important source of exposure via food. The fetus is exposed to PFOA via umbilical cord blood and newborns are exposed via breast milk. The intake for infants via breast milk can be greater than the intake via food for adults. Infants can also come into direct contact through carpeting, and swallowing dust can be an important contributor to exposure. PFOA is a substance of very high concern with respect to its health and environmental properties. PFOA is harmful to the reproductive system, carcinogenic, toxic and harmful to human health through repeated exposure and is also an irritant. PFOA does not degrade in the environment. PFOA is a substance similar to persistent, bio-accumulating and toxic (PBT) substances or a substance of equal concern. It is impossible to establish an acceptable level for substances with such properties in the environment, and emissions and exposure should be limited to the greatest extent possible. (UNEP/FAO/RC/CRC.14/8 Norwegian notification) 4.2 Criteria used Risk to human health and the environment. Relevance to other The notification states that concerns similar to those identified in Norway are likely to States and Region be encountered in other countries where the substance is used. PFOA is present in various globally distributed products. Adaptation of manufacturing methods to meet the Norwegian requirements may lead to reduced levels of PFOA in products in other countries as well. Several textile brands have phased out the use of perfluorinated compounds for water repellence treatment because of the negative attention directed at such compounds by various stakeholders. The notification also cites Norway’s “Evaluation of consequences of regulating PFOA and selected salts and esters of PFOA in consumer products”, according to which PFOA is transported long distances via air and sea currents, and its presence has been detected in the Arctic in a variety of species, including sea birds, seals and polar bears. The substance has also been identified as CMR and PBT, which are relevant concerns for any state or region in which PFOA may be released. 5 Alternatives EPA's review of alternatives to perfluorinated chemical substances has been ongoing since 2000 and is consistent with the approaches to alternatives encouraged under the 28 2010/15 PFOA Stewardship Program. Through June 2008, over 100 alternatives of various types have been received and reviewed by EPA. https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/fact-sheet- 20102015-pfoa-stewardship-program Additional information on alternatives could also be found in these two publications: OECD/UNEP Global PFC Group, Synthesis paper on per- and polyfluorinated chemicals (PFCs), 2013. Wang, Z., Cousins, I.T., Scheringer, M., Hungerbühler, K., 2013. Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors. Environ Int 60, 242-248 (UNEP/FAO/RC/CRC.14/8 Norwegian notification) 6 Waste The notifying Party did not provide information on waste management of PFOA or management articles containing it. 7 Other None. 29 Annex 3 – Addresses of designated national authorities Canada C From PIC website (18 December, 2018): Phone: +1 819 420 8047 Name: Ms. Nathalie Morin Fax: +1 819 938 4218 Job title: Director Email: [email protected] Department: Chemical Production Division Institution: Environment and Climate Change Canada Postal address: 351 St. Joseph Boulevard K1A OH3 Gatineau Québec Canada Norway C From PIC website (18 December, 2018): Name: Ms. Trine Celius Phone: +47 735 80 500 Job title: Senior Advisor Rotterdam Convention Designated Fax: +47 735 80 501 National Authority for Industrial Chemicals and Biocides Email: [email protected], Institution: Norwegian Environment Agency [email protected] Postal address: Grensesvingen 7 0661 Oslo Norway Name: Ms. Christel Moræus Olsen Phone: +47 735 80 500 Job title: Senior Advisor, Rotterdam Convention Designated Fax: +47 735 80 501 National Authority for Industrial Chemicals and Biocides Email: [email protected], Department: Section for Biocides and Declaration of [email protected] Chemicals/ Chemicals and Waste Department Institution: Norwegian Environment Agency Postal address: Grensesvingen 7 0661 Oslo Norway C Industrial chemicals CP Pesticides and industrial chemicals 30 Annex 4 – References Regulatory actions Canada Prohibition of Certain Toxic Substances Regulations, 2012 (SOR/2012-285), as amended, 2016 (SOR/2016-252) under the Canadian Environmental Protection Act, 1999 (CEPA). http://www.gazette.gc.ca/rp-pr/p2/2016/2016-10-05/html/sor-dors252-eng.html Norway Chapter 2-32 of the Regulation related to restrictions of the manufacture, import and placing on the market of chemicals and other products hazardous to the human health and the environment (Product Regulation). Act no. 922 of June 2004. Supporting documentation provided by Canada  Government of Canada. August 2012a. Screening Assessment Report on Perfluorooctanoic Acid, Its Salts and Its Precursors. http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=370AB133-1  Government of Canada. August 2012b. Proposed Risk Management Approach for Perfluorooctanoic Acid (PFOA), its Salts, and its Precursors and Long-Chain (C9-C20) Perfluorocarboxylic Acids (PFCAs), their Salts, and their Precursors. http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=451C95ED-1  Environment Canada and Health Canada. October 2016. Regulatory Impact Analysis Statement, Regulations Amending the Prohibition of Certain Toxic Substances Regulations, 2012. http://www.gazette.gc.ca/rp-pr/p2/2016/2016-10-05/html/sor-dors252-eng.html Supporting documentation provided by Norway  PFOA in Norway; Survey on national sources, TA-2354/2007. Available online at: http://www.miljodirektoratet.no/old/klif/publikasjoner/2354/ta2354.pdf  Per- and polyfluorinated substances in the Nordic Countries Use, occurrence and toxicology TemaNord 2013:542  Perfluorinated alkylated substances (PFAS) in the Nordic environment. TemaNord 2004:552  Impact assessment of regulating perfluorooctanoic acid (PFOA) and individual PFOA salts and esters in consumer products. The Norwegian version is available online: «Vurdering av konsekvenser av regulering av PFOA og enkelte salter og estere av PFOA i forbrukerprodukter”. http://www.miljodirektoratet.no/Global/dokumenter/horinger/horing2010-1463_PFOA.pdf  Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. Scientific Opinion of the Panel on Contaminants in the Food chain. The EFSA Journal 2008, 653, 16-131  ECHA: Pentadecafluorooctanoic acid (PFOA) as a substance of very high concern because of its CMR and PBT properties. 14 June 2013.  Fromme, H.; Mosch, C.; Morovitz, M.; Alba-Alejandre, I.; Boehmer, S.; Kiranoglu, M.; Faber, F.; Hannibal, I.; Genzel-Boroviczény, O.; Koletzko, B.; Völkel, W. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 2010, 44, 7123–7129.  Thomsen, C.; Haug, L. S.; Stigum, H.; Frøshaug, M.; Broadwell, S. L.; Becher, G. Changes in concentrations of perfluorinated compounds, polybrominated diphenyl ethers, and polychlorinated biphenyls in Norwegian breast-milk during twelve months of lactation. Environ Sci Technol 2010, 44, 9550–9556.  Haug, L.S., Salihovic, S., Jogsten, I.E., Thomsen, C., van Bavel, B., Lindström, G., Becher,G. 2010a. Levels in food and beverages and daily intake of fluorinated compounds in Norway. Chemosphere, 80, 1137–1143.  Haug, L.S., Thomsen, C., Brantsæter, A.L., Kvalem, H.E., Haugen, M., Becker, G., Alexander, J., Meltzer, H.M., Knutsen, H.K. 2010b. Diet and particulary seafood are major sources of perfluorinated compounds in humans. Environ. Int., 36, 772–778. 31  Haug, L.S., Huber, S., Becher, G., Thomsen, C. 2011. Characterisation of human exposure pathways to perfluorinated compounds – comparing exposure estimates with biomarkers of exposure. Environ Int 37, 687–693.  Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge IS, van Loveren H, Løvik M, Nygaard UC. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related healthoutcomes in early childhood. J Immunotoxicol. 2013,10:373-9.  Daae et al 2009: Kjemisk eksponering og effekter på luftveiene blant profesjonelle skismørere, ISSN nr. 1502-0932  Smithwick M, Norstrom R.J., Mabury S.A., Solomon K., Evans T.J., Stirling I., Taylor M.K., Muir D.C.G. 2006. Temporal trends of perfluoroalkyl contaminants in polar bears (Ursus maritimus) from two locations in the North American arctic, 1972-2002. Environ. Sci. Technol. 40(4):1139-1143.  Dietz et al. 2008; “Increasing Perfluoroalkyl Contaminants in East Greenland Polar Bears (Ursus maritimus): A New Toxic Threat to the Arctic Bears”, Environ. Sci. Technol. 2008, 42, 2701–2707  Tom Erik Økland and Kristina Skoog; TA-2450/2008. Available online at: http://www.miljodirektoratet.no/old/klif/publikasjoner/2450/ta2450.pdf  Aquateam, 2010. Undersøkelse av miljøgifter ved fire norske renseanlegg: PFOA, Bisfenol A, Triklosan, Siloksan (D5), Dodecylfenol og 2,4,6-Tri-tert.betylfenol. [Study of priority substances in four Norwegian processing plants: PFOA, Bisphenol A, Triclosan, Siloksan (D5), Dodecylfenol og 2,4,6-Tri- tert.betylphenol] Klif TA 2636/2010. Available online at: http://www.miljodirektoratet.no/old/klif/publikasjoner/2636/ta2636.pdf  Evenset et al. 2005: Miljøgifter i marine sedimenter, Isfjorden, Svalbard. [Priority substances in marine sediments, Isfjordenm Svalbard.] Akvaplan-NIVA-rapport APN-414. 3341.  Bakke, T., Fjeld, E., Skaare, B., Berge. J.A., Green, N., Ruus, A., Schlabach, M., and Botnen, H., 2007. Kartlegging av metaller og utvalgte nye organiske miljøgifter 2006. Krom, arsen, perfluoralkylstoffer, dikloretan, klorbenzener, pentaklorfenol, HCBD og DEHP. [Mapping out of metals and select new organic environmental toxins 2006; Chromium, arsenic, perfluoroalkyl substances, dichloroethane, chlorobenzenes, pentachlorophenol, HCBD and DEHP] SFT TA2284/2007. NIVA report 5464-2007. 105s.  Manø S, Herzke D, Schlabach M, Nye miljøgifter i luft [New priority substances in air] (TA-2408/2008). Available online at: http://www.miljodirektoratet.no/old/klif/publikasjoner/2408/ta2408.pdf  AMAP, 2009. Arctic Pollution 2009 (POPs, Human Health, Radioactivity). Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway. xi+83 pp  OECD/UNEP Global PFC Group, Synthesis paper on per- and polyfluorinated chemicals (PFCs), 2013.  Wang, Z., Cousins, I.T., Scheringer, M., Hungerbühler, K., 2013. Fluorinated alternatives to long-chain perfluoroalkyl carboxylic acids (PFCAs), perfluoroalkane sulfonic acids (PFSAs) and their potential precursors. Environ Int 60, 242-248  IFA, Institut fur Arbeitsscultz der Deutschen Gesetzlichen Unfallversicherung (http://gestis- en.itrust.de/nxt/gateway.dll/gestis_en/493012.xml?f=templates$fn=default.htm$3.0)  ECHA, 2014. Annex XV Restriction Report: Proposal For a Restriction - Perfluorooctanoic acid (PFOA), PFOA salts and PFOA - related substances http://echa.europa.eu/documents/10162/e9cddee6-3164-473d-b590-8fcf9caa50e7  Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. Scientific Opinion of the Panel on Contaminants in the Food chain. The EFSA Journal 2008, 653, 16-131.  ECHA, E.C.A., 2008. Summary Of Classification and Labelling: Harmonised classification – Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation) – PFOS. vol. 2012.  (ECHA), E.C.A., 2011. Opinions of the Committee for Risk Assessment on proposals for harmonised classification and labelling – PFOA. vol. 2012.  ECHA/RAC/CLH report 2011. Annex 1, Background document to the Opinion proposing harmonised classification and labelling at Community level of Perfluorooctanoic acid (PFOA).  OECD, 2006, SIDS Initial Assessment Report PFOA. 32  Environment Canada (2012): Screening Assessment Report; Perfluorooctanic Acid, its Salts, and its Precursors.  Verreault J, Berger U, Gabrielsen GW. 2007. Trends of perfluorinated alkyl substances in herring gull eggs from two coastal colonies in northern Norway: 1983–2003. Environ Sci Technol 41(19): 6671–6677.  Bytingsvik J, van Leeuwen SP, Hamers T, Swart K, Aars J, Lie E, Nilsen EM, Wiig O, Derocher AE, Jenssen BM. Perfluoroalkyl substances in polar bear mother-cub pairs: a comparative study based on plasma levels from 1998 and 2008. Environ Int. 2012, 49:92-9. Other Documents UNEP/POPS/POPRC.12/11/Add.2. (2016). Risk profile on pentadecafluorooctanoic acid (CAS No: 335-67-1, PFOA, perfluorooctanoic acid), its salts and PFOA-related compounds. UNEP/POPS/POPRC.13/7/Add.2 (2017). Risk management evaluation on pentadecafluorooctanoic acid (CAS No: 335-67-1, PFOA, perfluorooctanoic acid), its salts and PFOA-related compounds. UNEP/POPS/POPRC-14/2. (2018) Report of the Persistent Organic Pollutants Review Committee on the work of its fourteenth meeting. UNEP/POPS/POPRC.14/6/Add.2 (2018). Addendum to the risk management evaluation on perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds. Schoeib, M., Harner, T., Webster, G.M., Lee, S.C., 2011. Indoor Sources of Poly- and Perfluorinated Compounds (PFCS) in Vancouver, Canada: Implications for Human Exposure. Environ. Sci. Technol. 2011, 45, 19, 7999- 8005. https://pubs.acs.org/doi/pdf/10.1021/es103562v) Yu, N., Guo, H., Yang, J., Jin, L., Wang X.,, Shi, W., Zhang, X., Yu, X., Wei, S. 2018. Non-Target and Suspect Screening of Per- and Polyfluoroalkyl Substances in Airborne Particulate Matter in China. Environ. Sci. Technol. 2018, 52, 8205−8214 Relevant guidelines and reference documents IPCS (2017): PERFLUOROOCTANOIC ACID. International Chemical Safety Card (ICSC) 1413. Available at: http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&p_card_id=1613 United Nations (2013): UN Recommendations on the Transport of Dangerous Goods - Model Regulations, Eighteenth revised edition. Available at: http://www.unece.org/trans/danger/publi/unrec/rev18/18files_e.html IMO (2016): International Maritime Dangerous Goods Code (IMDG Code). Available at: http://www.imo.org/en/Publications/IMDGCode/Pages/Default.aspx 33 Saatja: Kei Ohno Woodall <[email protected]> Saadetud: 25.02.2019 16:52 Adressaat: Kei Ohno Woodall <[email protected]> Teema: Rotterdam Convention - Invitation for comments on PFOA, its salts and PFOA-related compounds draft DGD internal proposal Tähtsus: Kõrgeim Dear Sir/Madam, Please find attached a letter inviting comments on the internal proposal of draft decision guidance document (DGD) for perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds. The fourteenth meeting of the Chemical Review Committee was held from 11 to 14 September 2018 in Rome. The meeting report is available on the Conventions website: . At the meeting, the Committee adopted decision CRC-14/5, by which it adopted the rationale for the Committees conclusion that the notifications of final regulatory action submitted by Norway and Canada in respect of those chemicals in the industrial category met the criteria of Annex II to the Convention, and recommended that the Conference of the Parties list PFOA, its salts and PFOA-related compounds in Annex III to the Convention as industrial chemicals. Pursuant to the workplan adopted by the Committee (UNEP/FAO/RC/CRC.14/10, annex III), the intersessional drafting group has prepared an internal proposal of the draft DGD on PFOA, its salts and PFOA-related compounds. You are invited to review the attached draft and submit your comments by e-mail to before 29 March 2019. The "working paper on preparing internal proposals and decision guidance documents for banned and severely restricted chemicals" is also attached for your information. Please contact me if you have any questions regarding this invitation. Best regards, Kei --- Kei Ohno Woodall Secretariat of the Basel, Rotterdam and Stockholm conventions 11-13 Chemin des Anémones CH 1219 Châtelaine, Geneva Tel.: +41 22 917 8201 Fax: +41 22 917 8098 Email:
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel